 EXHIBIT 2.1       

**EXHIBIT  2.1**

 

 

**EXECUTION  COPY** 

 



 



 

 



 

**AGREEMENT  AND PLAN OF MERGER**

 

 

**between**

 

 

**SUN  HEALTHCARE GROUP, INC.,**

 

 

**HORIZON  MERGER INC.**

 

 

**and**

 

 

**HARBORSIDE  HEALTHCARE CORPORATION**

 

 

 

**Dated  as of October 19, 2006**

 

 

 

 

 

 

 

 

 

 

   

 

 

 

 

 

 

**TABLE  OF CONTENTS**

 

 

 

         |   |   |  

**_Page_**

    
---|---|---|--- 
      |   |   |   
    **ARTICLE  I**   DEFINITIONS  |  

1

    
      |   |   |   
      | Section  1.1  | _Certain  Defined Terms _  |  

1

    
      | Section  1.2  | _Table  of Definitions_   |  

6

    
    

 

 

 

       **ARTICLE  II** THE MERGER  |  

8

    
---|--- 
      |   |   |   
        | Section  2.1  | _The  Merger_   |  

8 

    
      | Section  2.2  | _Closing;  Effective Time_   |  

8

    
      | Section  2.3  | _Effects  of the Merger_   |  

9

    
      | Section  2.4  | _Certificate  of Incorporation and Bylaws_  
|  

9

    
      | Section  2.5   | _Directors;  Officers_   |  

9

    
    

 

 

 

 

 

       **ARTICLE  III** CONVERSION OF SHARES  |  

9

    
---|--- 
      |   |   |   
        | Section  3.1  | _Effect  on Capital Stock, Warrants and
Company Stock Options_   |  

9

    
      | Section  3.2  | _Payment  for Shares, Warrants and Company
Stock Options_   |  

11

    
      | Section  3.3  | _Stockholder  Representative_   |  

14

    
    

 

 

 

 

 

 

       **ARTICLE  IV** REPRESENTATIONS AND WARRANTIES OF THE COMPANY  |
 

15

    
---|--- 
      |   |   |   
        | Section  4.1  | _Organization  and Qualification_   |  

15

    
      |  

Section  4.2

    | _ Authority_  |  

15

    
      | Section  4.3  | _No  Conflict; Required Filings and Consents_
  |  

16

    
      | Section  4.4  | _Capitalization_   |  

16

    
      | Section  4.5   | _Equity  Interests_   |  

17

    
      | Section  4.6  | _Financial  Statements; No Undisclosed
Liabilities_   |  

17

    
      | Section  4.7  | _Absence  of Certain Changes or Events_   |
 

18

    
      | Section  4.8  | _Compliance  with Law; Permits_   |  

18

    
      | Section  4.9  | _Litigagtion_   |  

19

    
      | Section  4.10  | _Employee  Benefit Plans_   |  

19

    
      | Section  4.11  | _Labor  and Employment Matters_   |  

21

    
      | Section  4.12  | _Insurance_   |  

22

    
      | Section  4.13  | _Real  Property_   |  

22

    
      | Section  4.14  | _Intellectual  Property_   |  

23

    
      | Section  4.15  | _Taxes_   |  

23

    
      | Section  4.16  | _Environmental  Matters_   |  

24

    
      | Section  4.17  | _Material  Contracts_   |  

25

    
      | Section  4.18  | _Brokers_   |  

26

    
      | Section  4.19  | _Indebtedness_   |  

26

    
      | Section  4.20  | _Medicaid/Medicare  Programs_   |  

26

    
    

 



 

 

 

 

 

 

 

 

i  

 

 

 

 

 

 

 

 

**TABLE  OF CONTENTS**

 

**(continued)**

 

 



 

         |   |   |  

**_Page_**

    
---|---|---|--- 
      |   |   |   
      | Section  4.21  | _HIPAA  Compliance_   |  

27

    
      | Section  4.22  | _Hill-Burton  Act_   |  

27

    
    

 

 

 

        

**ARTICLE V** REPRESENATATIONS  AND WARRANTIES OF ACQUIROR AND MERGERCO

    |  

27

    
---|--- 
      |   |   |   
        | Section  5.1  | _Organization  and Qualification_   |  

27 

    
      | Section  5.2  | _Authority_   |  

28

    
      | Section  5.3  | _No  Conflict; Required Filings and Consents_
  |  

28

    
      | Section  5.4  | _No  Prior Activities_   |  

28

    
      | Section  5.5   | _No  Outside Reliance_   |  

29

    
      | Section  5.6  | _Financing;  Solvency_   |  

 

29

 

    
      | Section  5.7  | _Brokers_   |  

30

    
    

 

 

 

 

 

       **ARTICLE VI** COVENANTS  |  

30

    
---|--- 
      |   |   |   
        | Section  6.1  | _Conduct  of Business Prior to Closing_  
|  

30

    
      |  

Section  6.2

    | _Covenants  Regarding Information_   |  

32

    
      | Section  6.3  | _Stockholder  Approval_   |  

32

    
      | Section  6.4  | _Notification  of Certain Matters_   |  

33

    
      | Section  6.5   | _No  Solicitation_   |  

33

    
      | Section  6.6  | _Takeover  Statutes_   |  

33

    
      | Section  6.7  | _Employee  Benefits_   |  

34

    
      | Section  6.8  | _Confidentiality_   |  

34

    
      | Section  6.9  | _Consents  and Filings; Further Assurances_
  |  

34

    
      | Section  6.10  | _Public  Announcements_   |  

35

    
      | Section  6.11  | _Directors\'  and Officers\'
Indemnification_   |  

36

    
      | Section  6.12  | _Financing_   |  

37

    
      | Section  6.13  | _Financial  Statements_   |  

39

    
      | Section  6.14  | _Parachute  Payments_   |  

40

    
      | Section  6.15  | _Stockholder  Information_   |  

40

    
      | Section  6.16  | _Transaction  Expenses_   |  

40

    
      | Section  6.17  | _Transaction  Expense Tax Benefit Payments_
  |  

40

    
      | Section  6.18  | _Preferred  Stock Redemption_   |  

42

    
    

 

 

 

 

 

 

 

 

 

 

 

 

 

 

       **ARTICLE  VII** CONDITIONS TO CLOSING  |  

42

    
---|--- 
      |   |   |   
        | Section  7.1  | _General  Conditions_   |  

42

    
      | Section  7.2  | _Conditions  to Obligations of the Company_
  |  

43

    
      | Section  7.3  | _Conditions  to Obligations of Acquiror and
MergerCo_   |  

43

    
    

 

 

 

 


 

 

 

 

 

 

 

ii  

 

 

 

 

 

 

 

 

 

**TABLE  OF CONTENTS**

 

**(continued)**

 

 



 

         |   |   |  

**_Page_**

    
---|---|---|--- 
      |   |   |   
    **ARTICLE  VIII** TERMINATION  |  

44

    
      |   |   |   
      | Section  8.1  | _Termination_   |  

44

    
      | Section  8.2  | _Effect  of Termination_   |  

45

    
    

 

 

 

 

 

 

       **ARTICLE IX** GENERAL  PROVISIONS  |  

46

    
---|--- 
      |   |   |   
        | Section  9.1  | _Nonsurvival  of Representations,
Warranties and Covenants_   |  

46

    
      |  

Section  9.2

    | _Fees  and Expenses_   |  

46

    
      | Section  9.3  | _Amendment  and Modification_   |  

46

    
      | Section  9.4  | _Waiver_   |  

46

    
      | Section  9.5   | _Notices_   |  

46

    
      | Section  9.6  | _Interpretation_   |  

47

    
      | Section  9.7  | _Entire  Agreement_   |  

48

    
      | Section  9.8  | _No  Third Party Beneficiaries_   |  

48

    
      | Section  9.9  | _Governing  Law_   |  

48

    
      | Section  9.10  | _Submission  to Jurisdiction_   |  

48

    
      | Section  9.11  | _Disclosure  Generally_   |  

49

    
      | Section  9.12  | _Personal  Liability_   |  

49

    
      | Section  9.13  | _Assignment;  Successors_   |  

49

    
      | Section  9.14  | _Enforcement_   |  

49

    
      | Section  9.15  | _Severability_   |  

49

    
      | Section  9.16  | _Waiver  of Jury Trial_   |  

 

50

 

    
      | Section  9.17  | _Counterparts_   |  

50

    
      | Section  9.18  | _Facsimile  Signature_   |  

 

50

 

    
      | Section  9.19  | _Time  of Essence_   |  

50

    
      | Section  9.20  | _No  Consequential Damages_   |  

50

    
      | Section  9.21  | _Disclaimer  of Implied Warranties_   |  

50

    
    

 

 

 

 

 

 

_Exhibits_

 

 



 

Exhibit  A -  Form of  Certificate of Merger

 



 

 

 

 

 

 

 

 

 

iii  

 

 

 

 

 


 

**AGREEMENT  AND PLAN OF MERGER**

 

 

THIS  AGREEMENT AND PLAN OF MERGER, dated as of October 19, 2006 (this "
_Agreement_ "),  is  between SUN HEALTHCARE GROUP, INC., a Delaware
corporation (" _Acquiror_ "),  HORIZON MERGER INC., a Delaware corporation
and a wholly-owned subsidiary of  Acquiror (" _MergerCo_ ")  and 
HARBORSIDE HEALTHCARE CORPORATION, a Delaware corporation (the " _Company_ ").

 

 

**RECITALS**

 

 

A. Acquiror  has formed MergerCo for the purpose of merging it with and into
the Company  (the  " _Merger_ ")  in  order to acquire the Company as a
wholly-owned subsidiary.

 

 

B. The  Boards of Directors of each of Acquiror, MergerCo and the Company
have  (i) determined that the consideration to be paid in the merger of
MergerCo  with and into the Company upon the terms and subject to the
conditions set  forth  herein would be advisable, fair and in the best
interests of their respective  stockholders and (ii) approved the Merger upon
the terms and conditions set  forth in this Agreement in accordance with
Delaware General Corporation Law  (the  " _DGCL_ ").

 

 

C. The  Board  of Directors of the Company has resolved to submit this
Agreement to a vote  of  the stockholders of the Company and, subject to the
terms hereof, to recommend  approval of this Agreement to the stockholders of
the Company entitled to vote  thereon.

 

 

D. The  Stockholders entitled to vote on the Merger have indicated their
willingness  to  deliver, immediately following the execution and delivery
of this Agreement,  a  written consent in compliance with the DGCL that
approves and adopts this  Agreement and the transactions contemplated hereby.

 

 

E. Acquiror,  MergerCo and the Company desire to make certain
representations, warranties,  covenants and agreements in connection with the
Merger and also to prescribe  various conditions to the Merger.

 

 

**AGREEMENT**

 

 

NOW,  THEREFORE, in consideration of the representations, warranties,
covenants and  agreements contained in this Agreement, the parties agree as 
follows:

 

 

**ARTICLE  I**

 

**DEFINITIONS**

 

 

Section  1.1 _Certain  Defined Terms_.  In  addition to the other words
and terms defined elsewhere in this Agreement,  as  used in this Agreement,
the following words and terms shall have the meanings  specified or referred
to below:


 

 

 

 

 

 

 

   

 

 

 

 

 

 

  " _Action_ "  means  any claim, action, suit, arbitration or proceeding
by or before any Governmental  Authority.

 

 

" _Affiliate_ "  means,  as applied to any Person, any other Person directly
or indirectly controlling,  controlled by or under common control with, that
Person. For the purposes of  this definition, " _control_ "  (including with
correlative meanings, the terms " _controlling_ ",  " _controlled  by_ ", 
and  " _under  common control with_ ")  as  applied to any Person, means
the possession, directly or indirectly, of the  power to direct or cause the
direction of the management and policies of that  Person, whether through
ownership of voting securities or by contract or  otherwise.

 

 

" _Business  Day_ "  means  any day that is not a Saturday, a Sunday or
other day on which banks are  required or authorized by Law to be closed in
The City of New York.

 

 

" _Bylaws_ "  means  the bylaws of the Company, as in effect immediately
prior to the Effective  Time. 

 

 

" _Certificate  of Designations_ "  means  the Company\'s Certificate of
Designations with respect to its Preferred  Stock.

 

 

" _Certificate  of Incorporation_ "  means  the certificate of
incorporation of the Company, as in effect immediately prior  to the
Effective Time.

 

 

" _Class  A Common Stock_ "  means  the Class A Common Stock, par value
$0.01 per share, of the Company. 

 

 

" _Class  B Common Stock_ "  means  the Class B Common Stock, par value
$0.01 per share, of the Company. 

 

 

" _Class  C Common Stock_ "  means  the Class C Common Stock, par value
$0.01 per share, of the Company. 

 

 

" _Class  D Common Stock_ "  means  the Class D Common Stock, par value
$0.01 per share, of the  Company.

 

 

" _Code_ "  means  the United States Internal Revenue Code of 1986, as
amended through the date  hereof.

 

 

" _Common  Stock_ "  means,  collectively, the Class A Common Stock, the
Class B Common Stock, the Class  C  Common Stock, the Class D Common Stock
and the Undesignated Common Stock. 

 

 

" _Company  Stock Options_ "  means  options to purchase shares of the
Common Stock.

 

 

" _Company  Transaction Expenses_ "  means  the aggregate amount of the
costs, fees and expenses incurred by the Company  in  accordance with
_Section  9.2_   (except  for expenses paid prior to August 31, 2006 that
do not exceed $700,000 in the  aggregate).


 

 

 

 

 

 

 

2  

 

 

 

 

 

 

 

" _Employee  Merger Payments_ "  means  any employee bonuses or similar
compensation payable as a result of or in  connection with the Merger
including, without limitation, the amounts set forth  on Schedule 9.2(a)
(excluding any amounts payable by Acquiror pursuant to  _Section  9.2(b)_ ).

 

 

" _Encumbrance_ "  means  any charge, claim, mortgage, lien, option, pledge,
security interest or other  restriction of any kind (other than those created
under applicable securities  laws).

 

 

" _Environmental  Laws_ "  means  any Laws or common law in effect as of
the date hereof relating to pollution  or  protection of the environment,
natural resources and human health and safety,  including those relating to
Releases of Hazardous Materials or otherwise  relating to the treatment,
storage, transport or handling of Hazardous  Materials.

 

 

" _Environmental  Permits_ "  means  all Permits under any Environmental
Law.

 

 

" _Facilities_ "  means  all hospitals, outpatient clinics, long-term care
facilities, nursing homes,  rehabilitation facilities, assisted living
facilities, independent living  facilities or other healthcare facilities
operated by the Company or any of  its  Subsidiaries.

 

 

" _Fully  Diluted Shares_ "  means  (i) the aggregate number of shares of
Common Stock (excluding Common Stock  owned by MergerCo, any Affiliate of
MergerCo or any Subsidiary of the Company)  issued and outstanding as of the
Closing Date _plus_   (ii) the aggregate number of shares of Common Stock
issuable upon exercise  of all Company Stock Options and Warrants issued and
outstanding as of the  Closing Date with an exercise price below the Per
Share Merger Consideration  _plus_   (iii)  the aggregate number of shares
of Common Stock issuable on the Closing Date  upon  conversion of the
Preferred Stock issued and outstanding as of the Closing  Date  in
accordance with the terms of the Certificate of Designations.

 

 

" _GAAP_ "  means  United States generally accepted accounting principles as
in effect on the  date  hereof.

 

 

" _Governmental  Authority_ "  means  any United States federal, state or
local governmental, regulatory or  administrative authority, agency or
commission or any judicial or arbitral  body.

 

 

" _Hazardous  Materials_ "  means  all materials, wastes or substances
defined by, or regulated under, any  Environmental Laws as a hazardous waste,
hazardous material, hazardous  substance, extremely hazardous waste,
restricted hazardous waste, contaminant,  pollutant, toxic waste, or toxic
substance, including petroleum and petroleum  products, asbestos, lead, toxic
mold, radioactive materials and polychlorinated  biphenyls.

 

 

" _Indebtedness_ "  means  (i) all indebtedness for borrowed money, (ii) any
other indebtedness that is  evidenced by a note, bond, debenture, draft or
similar instrument, (iii) notes  payable, (iv) letters of credit and any
other agreements relating to the  borrowing of money or extension of credit
(excluding lines of credit), (v)  all  obligations under financing or
capital leases (as defined by GAAP) and (vi)  all  guarantees and
arrangements having the economic effect of a guarantee of or  by a  Person
of any Indebtedness of any other Person.


 

 

 

 

 

 

 

3  

 

 

 

 

 

 

 

" _Intellectual  Property_ "  means  (i) trade names, trademarks and
service marks, domain names, trade dress and  similar rights, and
applications to register any of the foregoing;  (ii) patents and patent
applications; (iii) copyrights (whether registered  or unregistered) and
applications for registration and (iv) confidential and  proprietary
information, including trade secrets and know-how.

 

 

" _IRS_ "  means  the Internal Revenue Service of the United States.

 

 

" _Knowledge_ ",  with  respect to the Company, means the actual (but not
constructive or imputed)  knowledge of the persons listed on _Schedule 
1.1(a)_   as of  the date of this Agreement (or, with respect to a
certificate delivered pursuant  to this Agreement, as of the date of delivery
of such certificate) without  any  implication of verification or
investigation concerning such  knowledge.

 

 

" _Law_ "  means  any statute, law, ordinance, regulation, rule, code,
injunction, judgment,  decree or order of any Governmental Authority.

 

 

" _Leased  Real Property_ "  means  the real property leased by the Company
or any of its Subsidiaries, in each  case, as tenant, together with, to the
extent leased by the Company or its  Subsidiaries, all buildings and other
structures, facilities or improvements  located thereon and all easements,
licenses, rights and appurtenances of the  Company or any of its Subsidiaries
relating to the foregoing.

 

 

" _Loan  and Security Agreement_ "  means  the Second Amended and Restated
Loan and Security Agreement, dated April 28,  2006, by and among the Company,
General Electric Capital Corporation, Merrill  Lynch Capital and the
financial institutions from time to time party  thereto.

 

 

" _Material  Adverse Effect_ "  means  any event, change, circumstance,
effect or state of facts that is materially  adverse to (i) the business,
financial condition or results of operations of  the  Company and its
Subsidiaries, taken as a whole or (ii) the ability of the  Company to perform
its obligations under this Agreement or to consummate the  transactions
contemplated hereby, except in the case of clause (i) for any  event, change,
circumstance, effect or state of facts arising out of or  attributable to any
of the following, either alone or in combination:  (a) general national,
international or regional economic, political or  financial conditions,
including any such event, change, circumstance, effect  or  state of facts
resulting from acts of war (whether or not declared) or terrorism  or other
force majeure events,  but  only if they do not materially
disproportionately affect the Company and its  Subsidiaries taken as a whole
relative to the industry in which the Company  and  its Subsidiaries operate
generally,  (b)  generally affecting the industry in which the Company and
its Subsidiaries  operate generally (including legislative, legal and
regulatory changes), but  only if they do not materially disproportionately
affect the Company and its  Subsidiaries taken as a whole relative to the
industry in which the Company  and  it Subsidiaries operate generally, (c)
actions taken pursuant to or in  accordance with this Agreement or at the
request of Acquiror, (d) changes in  Laws or GAAP and (e) the execution or
delivery of this Agreement or the  announcement or pending status of the
transactions contemplated by this  Agreement.


 

 

 

 

 

 

 

4  

 

 

 

 

 

 

 

" _Merger  Consideration_ "  means  the sum of (i) the Purchase Price
_plus_   (ii) the  aggregate exercise price of all unexercised Company Stock
Options and Warrants  outstanding immediately prior to the Effective Time
with an exercise price  below  the Per Share Merger Consideration _minus_  
(iii)  the amount of the Company Transaction Expenses.

 

 

" _Owned  Real Property_ "  means  the real property owned by the Company
or any of its Subsidiaries, together  with  all buildings and other
structures, facilities or improvements located thereon  and all easements,
licenses, rights and appurtenances of the Company or any  of  its
Subsidiaries relating to the foregoing.

 

 

" _Per  Share Merger Consideration_ "  means  an amount, rounded to the
nearest $0.01, equal to the Merger Consideration  _divided_   by the  Fully
Diluted Shares.

 

 

" _Permit_ "  means  any permit, license, franchise, approval, certificate,
consent, waiver,  concession, exemption, order, registration, notice,
certificate of need or  other  authorization granted by any Governmental
Authority.

 

 

" _Permitted  Encumbrance_ "  means  (i) statutory liens for current Taxes
not yet due or delinquent (or which may  be  paid without interest or
penalties) or the validity or amount of which is being  contested in good
faith by appropriate proceedings, (ii) mechanics\', carriers\',  workers\',
repairers\' and other similar liens arising or incurred in the ordinary 
course of business for obligations not yet due or payable or not yet
delinquent,  or the validity or amount of which is being contested in good
faith by  appropriate proceedings, or pledges, deposits or other liens
securing the  performance of bids, trade contracts, leases or statutory
obligations (including  workers\' compensation, unemployment insurance or
other social security  legislation), (iii) zoning, entitlement, conservation
restriction and other  land  use and environmental regulations promulgated
by Governmental Authorities and  (iv) all exceptions, restrictions,
easements, imperfections of title, charges,  rights-of-way and other
Encumbrances on real property that do not materially  interfere with the
present use of the real property of the Company and its  Subsidiaries taken
as a whole.

 

 

" _Person_ "  means  an individual, corporation, partnership, limited
liability company, limited  liability partnership, syndicate, person, trust,
association, organization  or  other entity, including any Governmental
Authority, and including any successor,  by merger or otherwise, of any of
the foregoing.

 

 

" _Preferred  Purchase Price_ "  means  (i) the Per Share Merger
Consideration _times_   (ii) the  number of shares of Common Stock issuable
upon conversion on the Closing Date  (in accordance with the terms of the
Certificate of Designations) of the  Preferred Stock outstanding as of the
Closing Date, as designated in writing  by  the Stockholder Representative
in accordance with _Section  3.1(h)_.

 

 

" _Preferred  Stock_ "  means  the Company\'s 13% Convertible Exchangeable
Preferred Stock, par value $0.01  per  share.

 

 

" _Present  Fair Saleable Value_ "  means  the amount that may be realized
if the aggregate assets of the Surviving  Corporation (including goodwill)
are sold as an entirety with  reasonable


 

 

 

 

 

 

 

5  

 

 

 

 

 

 

promptness  in an arms-length transaction under present conditions for the
sale of  comparable business enterprises.

 

 

" _Purchase  Price_ "  means  $349,400,000.

 

 

" _Release_ "  means  any release, spill, emission, discharge, leaking,
pumping, pouring, dumping,  injection, deposit, disposal, dispersal, leaching
or migration of Hazardous  Materials into the environment (including, ambient
air, surface water,  groundwater and surface or subsurface strata).

 

 

" _Representatives_ "  means,  with respect to any Person, the officers,
employees, agents, accountants,  advisors, bankers and other representatives
of such Person.

 

 

" _Return_ "  means  any return, declaration, report, statement, information
statement and other  document required to be filed with respect to Taxes.

 

 

" _Shares_ "  means  the shares of Common Stock and Preferred Stock
outstanding immediately prior  to  the Effective Time.

 

 

" _Stockholder_ "  means  each holder of Shares.

 

 

" _Subsidiary_ "  means,  with respect to any Person, any other Person of
which at least 50% of the  outstanding voting securities or other voting
equity interests are owned,  directly or indirectly, by such first Person.

 

 

" _Tax_ "  or  " _Taxes_ "  (and  with correlative meaning, " _Taxable_
",  " _Taxation_ "  and  " _Taxing_ ")  means  any and all taxes of any
kind (together with any and all interest, penalties,  additions to tax and
additional amounts imposed with respect thereto) imposed  by  any
Governmental Authority.

 

 

" _TRICARE_ "  means,  collectively, a program of medical benefits covering
former and active members  of the uniformed services and certain of their
dependents, financed and  administered by the United States Departments of
Defense, Health and Human  Services and Transportation, which program was
formerly known as the "Civilian  Health and Medical Program of the Uniformed
Services (CHAMPUS)".

 

 

" _Undesignated  Common Stock_ "  means  the Common Stock (as defined in
the Certificate of Incorporation), par value  $0.01 per share, of the
Company.

 

 

" _Warrants_ "  means  the Series B Warrants and Series C Warrants of the
Company, entitling the  holders thereof to purchase shares of Common Stock.

 

 

" _Wire  Transfer Recipients_ "  means  the Stockholders and holders of
Warrants designated in writing by the Company  no  later than 3 Business
Days prior to the Closing.

 

 

Section  1.2 _Table  of Definitions_.  The  following words and terms have
the meanings set forth in the Sections referenced  below:

 




 

 

 

 

 

 

 

 

 

6  

 

 

 

 

 

 

 

 

       _Definition_   |   _Location_   
---|--- 
      |   
    2006  Year-End Required Financial Information  | 6.13(b)  
    Acquiror  | Preamble  
    Acquiror  Disclosure Schedules  | Article  V  
    Affected  Employees  | 6.7(a)  
    Agreement  | Preamble  
    Balance  Sheet  | 4.6(a)  
    Bank  Financing  | 5.6(a)  
    Bank  Syndication Period  | 6.12(b)  
    Bond  Financing  | 6.12(a)  
    Bridge  Financing  | 5.6(a)  
    Certificate  of Merger  | 2.2(b)  
    Certificates  | 3.2(c)  
    Closing  | 2.2(a)  
    Closing  Date  | 2.2(a)  
    COD  Amendment  | 3.1(g)  
    Commitment  Letter  | 5.6(a)(i)  
    Company  | Preamble  
    Company  Health Care Licenses  | 4.8(b)  
    Company  Stockholder Approval  | 4.2(a)  
    Confidentiality  Agreement  | 6.8  
    Consideration  Certificate  | 3.1(h)  
    CP  Satisfaction Date  | 6.12(a)  
    Current  Transaction Expense Tax Benefit Amount  | 6.17(a)  
    DandO  Indemnified Liabilities  | 6.11(a)  
    DandO  Indemnified Parties  | 6.11(a)  
    Deductible  Transaction Expenses  | 6.17(a)  
    DGCL  | Recitals  
    Disclosure  Schedules  | Article  IV  
    Dissenting  Shares  | 3.1(e)  
    Effective  Time  | 2.2(b)  
    Employee  Plans  | 4.10(a)  
    ERISA  | 4.10(a)  
    Financial  Statements  | 4.6(a)  
    Financing  | 5.6(a)(i)  
    Financing  Period  | 6.12(b)  
    Former  Properties  | 4.16(a)  
    Future  Stockholder Benefit  | 6.17(b)  
    Future  Transaction Expense Tax Benefit  | 6.17(b)  
    Health  Care Licenses  | 4.8(b)  
    HIPAA  | 4.17(a)(vi)  
    HSR  Act  | 4.3(b)  
    Interim  Financial Statements  | 4.6(a)  
    Knowledge  of Acquiror  | 5.3(b)  
    Lenders  | 5.6(a)(i)  
    

 

 


 

 

 

 

 

 

 

7  

 

 


 

       _Definition_   | _Location_   
---|--- 
      |   
    Letter  of Transmittal  | 3.2(c)  
    Majority  Holders  | 3.3(b)  
    March  2007 Required Financial Information  | 6.13(c)  
    Marketing  Period  | 6.12(b)  
    Material  Contracts  | 4.17(a)  
    Merger  | Recitals  
    MergerCo  | Preamble  
    Order  | 4.8(b)  
    Outside  Funding Date  | 6.12(b)  
    Paying  Agent  | 3.2(a)  
    Payment  Fund  | 3.2(a)  
    Pre-Funding  Condition  | 6.12(b)  
    Rabbi  Trust  | 4.10(g)  
    Required  Financial Information  | 6.13(d)  
    Securities  Act  | 6.13(a)  
    September  2006 Required Financial Information  | 4.10(g)  
    SERP  | 6.17(a)  
    Short  2007 Tax Year  | 5.6(d)  
    Solvency  | 5.6(d)  
    Solvent  | 6.17(a)  
    Stockholder  Benefit  | 3.3(a)  
    Surviving  Corporation  | 2.1  
    Termination  Date  | 8.1(c)  
    Termination  Fee  | 8.2  
    Total  Merger Payment  | 3.1(h)  
    USRPHC  | 4.15  
    WARN  Act  | 4.11(c)  
    

 

 



 

**ARTICLE  II**

 

**THE  MERGER**

 

 

Section  2.1 _The  Merger_.  Upon  the terms and subject to the conditions
of this Agreement, at the Effective  Time  and in accordance with the DGCL,
MergerCo shall be merged with and into the  Company pursuant to which (i) the
separate corporate existence of MergerCo  shall  cease, (ii) the Company
shall be the surviving corporation in the Merger  (the " _Surviving 
Corporation_ ")  and  shall continue its corporate existence under the laws
of the State of Delaware  as a wholly-owned Subsidiary of Acquiror and (iii)
all of the properties,  rights, privileges, powers and franchises of the
Company will vest in the  Surviving Corporation, and all of the debts,
liabilities, obligations and duties  of the Company will become the debts,
liabilities, obligations and duties of  the  Surviving Corporation.

 

 

Section  2.2 _Closing;  Effective Time_.


 

 

 

 

 

 

 

8  

 

 

 

 

 

 

 

(a) The  closing of the Merger (the " _Closing_ ")  shall  take place at
the offices of Gibson, Dunn and Crutcher LLP, 200 Park Avenue,  New York, New
York, at 10:00 A.M., Eastern Standard time, on the third  Business Day
following the satisfaction or, to the extent permitted by  applicable Law,
waiver of all conditions to the obligations of the parties  set  forth in
_Article  VII_   (other  than such conditions as may, by their terms, only
be satisfied at the Closing  or  on the Closing Date), or at such other
place or at such other time or on such  other date as the parties mutually
may agree in writing; _provided_ ,  _however_ ,  that  notwithstanding the
satisfaction or waiver of the conditions set forth in  _Article  VII_ , 
the  parties shall not be required to effect the Closing until the earliest
to occur  of (i) a date during the applicable Financing Period to be
specified by Acquiror  on no less than three Business Days\' notice to the
Company, (ii) the final  day  of the applicable Financing Period, and (iii)
the Termination Date. The day  on  which the Closing takes place is herein
referred to as the " _Closing  Date_ ".

 

 

  (b) As  soon  as practicable on the Closing Date, the parties shall cause
a certificate of  merger substantially in the form attached as _Exhibit  A_
  to be  executed and filed with the Secretary of State of the State of
Delaware (the  " _Certificate  of Merger_ ")  in  accordance with the
relevant provisions of the DGCL. The Merger shall become  effective upon the
filing of the Certificate of Merger with the Secretary of  State of the State
of Delaware or at such later time as the parties shall agree  and as shall be
specified in the Certificate of Merger. The date and time when  the Merger
shall become effective is herein referred to as the " _Effective  Time_ ".

 

 

Section  2.3 _Effects  of the Merger_.  The  Merger shall have the effects
provided for herein and in the applicable  provisions of the DGCL.

 

 

Section  2.4 _Certificate  of Incorporation and Bylaws_.  From  and after
the Effective Time, (a) the Certificate of Incorporation of the  Company
shall be the certificate of incorporation of the Surviving Corporation  until
amended in accordance with the provisions thereof and applicable Law  and 
(b) the Bylaws shall be amended and restated to be identical to the bylaws 
of MergerCo and as so amended and restated shall be the bylaws of the
Surviving  Corporation until amended in accordance with the provisions
thereof and  applicable Law.

 

 

Section  2.5 _Directors;  Officers_.  From  and after the Effective Time,
(a) the directors of MergerCo serving immediately  prior to the Effective
Time shall be the directors of the Surviving Corporation  until the earlier
of their resignation or removal or until their respective  successors are
duly elected and qualified, as the case may be, and (b) the  officers of the
Company serving immediately prior to the Effective Time shall  be  the
officers of the Surviving Corporation until the earlier of their resignation 
or removal or until their respective successors are duly elected and
qualified,  as the case may be.

 

 

**ARTICLE  III**

 

**CONVERSION  OF SHARES**

 

 

Section  3.1 _Effect  on Capital Stock, Warrants and Company Stock
Options_.  At the  Effective Time, by virtue of the Merger and without any
further action on the  part of the holders of any Shares, Company Stock
Options, Warrants or any shares  of capital stock of MergerCo:


 

 

 

 

 

 

 

9  

 

 

 

 

 

 

 

  (a) _Capital  Stock of MergerCo_.  Each  share of common stock, par
value $0.001 per share, of MergerCo issued and  outstanding immediately prior
to the Effective Time shall be converted into  and  become 1 share of Class
D Common Stock of the Surviving  Corporation.

 

 

(b) _Common  Stock, Warrants and Company Stock Options Owned by Company
Subsidiaries,  Acquiror or MergerCo_.  Each  Share, Warrant and Company
Stock Option that is held by any Subsidiary of the  Company, and each Share,
Warrant and Company Stock Option that is held by  Acquiror, MergerCo or any
Affiliate of Acquiror or MergerCo, shall automatically  be cancelled and
retired and shall cease to exist, and no cash or other  consideration shall
be delivered or deliverable in exchange  therefor.

 

 

(c) _Conversion  of Common Stock_.  Except  for shares of Common Stock that
are subject to _Sections  3.1(b)_ ,  _3.1(d)_   or  _3.1(e)_   each 
share of Common Stock shall be cancelled and extinguished and be converted 
automatically into and become a right to receive the Per Share Merger 
Consideration.

 

 

(d) _Treasury  Shares_.  Each  Share that is held in the treasury of the
Company or owned by the Company or  any  of its wholly-owned Subsidiaries
shall automatically be cancelled and retired  and shall cease to exist, and
no cash or other consideration shall be delivered  or deliverable in exchange
therefor.

 

 

(e) _Dissenting  Shares_.  Notwithstanding anything in this Agreement to the
contrary, Shares (other than  any Shares to be cancelled pursuant to
_Sections  3.1(b)_   and  _3.1(d)_ )  outstanding immediately prior to the
Effective Time and held by a holder who  has  not voted in favor of the
Merger or consented thereto in writing and who has  properly demanded
appraisal for such Shares in accordance with Section 262  of  the DGCL, if
such Section provides for appraisal rights for such Shares in  the  Merger
(" _Dissenting  Shares_ "),  shall  not be converted into or be
exchangeable for the right to receive the Per Share  Merger Consideration 
(with  respect to shares of Common Stock) or the pro rata portion of the
Preferred  Purchase Price (with respect to shares of Preferred Stock)
unless  and until such holder fails to perfect or withdraws or otherwise
loses his  or  her right to appraisal and payment under the DGCL. If, after
the Effective  Time,  any such holder fails to perfect or withdraws or loses
his or her right to  appraisal, such Dissenting Shares shall thereupon be
treated as if they had  been  converted as of the Effective Time into the
right to receive the Per Share  Merger Consideration (with respect to shares
of Common Stock) or the pro rata  portion of the Preferred Purchase Price
(with respect to shares of Preferred  Stock), in each case, if any, to which
such holder is entitled, without  interest. The Company shall give Acquiror
(i) reasonably prompt notice of  any demands received by the Company for
appraisal of Shares pursuant to the  DGCL  and (ii) the opportunity to
participate in all negotiations and proceedings  with respect to such
demands. The Company shall not, except with the prior  written consent of
Acquiror (which consent shall not be unreasonably withheld),  make any
payment with respect to, or settle or offer to settle, such  demands.

 

 

(f) _Conversion  and Cancellation of Company Stock Options and Warrants_. 
Except  for Company Stock Options and Warrants that are subject to _Section 
3.1(b)_ ,  each  Company Stock Option and Warrant outstanding immediately
prior to the Effective  Time shall be cancelled and extinguished and be
converted automatically into  and  become a right to receive


 

 

 

 

 

 

 

10  

 

 

 

from  the  Company cash in an amount equal to the product of (i) the number
of Shares  for which such Company Stock Option or Warrant, as applicable, is
exercisable  and (ii) the excess of the Per Share Merger Consideration over
the per  share exercise price of such Company Stock Option or Warrant, as
applicable,  less any applicable Taxes deducted or withheld pursuant to
_Section 3.2(l)_.

 

 

(g) _Conversion  of Preferred Stock_.  Except  for shares of Preferred
Stock that are subject to _Sections  3.1(b)_ ,  _3.1(d)_   or  _3.1(e)_
,  each  share of Preferred Stock shall be cancelled and extinguished and be
converted  automatically into and become a right to receive a pro rata
portion of the  Preferred Purchase Price. The Certificate of Designations
shall be amended  promptly after the execution of this Agreement to permit
the Merger and the  transactions contemplated hereby (the " _COD  Amendment_
").

 

 

(h) _Calculation  of Certain Amounts._   Not  later than 3 Business Days
prior to the Effective Time, the Company shall  deliver to Acquiror an update
to _Schedule  4.4 of the Disclosure Schedules_   and a  certificate
executed by the Company setting forth the following information  (the  "
_Consideration  Certificate_ "):  (i)  the total amount of the Company
Transaction Expenses (whether incurred prior  to  Closing or expected to be
incurred following Closing), together with an itemized  break-down and
description of each Company Transaction Expense; (ii) the total  amount to be
paid by Acquiror to all holders of Shares, Company Stock Options  and
Warrants as a result of the consummation of the Merger and the other 
transactions contemplated hereby (the " _Total  Merger Payment_ ");  (iii) 
the amount and a detailed calculation of the Merger Consideration, the Per 
Share  Merger Consideration and the Fully Diluted Shares, (iv) the exercise
price  of  each Company Stock Option and Warrant; (v) the portion of the
Total Merger  Payment to be paid to the holders of each of (A) the Company
Stock Options,  (B)  the Warrants and (C) each class and series of the
Shares; (vi) the total amounts  to be paid to (A) the Paying Agent, (B) the
Wire Transfer Recipients and (C)  the  holders of Company Stock Options; and
(vii) such other information as Acquiror  may reasonably request with respect
to the numbers of Shares, Warrants and  Company Stock Options held by each
holder thereof and the amounts to be paid  to  each such holder as a result
of the consummation of the Merger. At the Closing,  the Company shall cause
the Stockholder Representative to deliver a certificate,  in the form agreed
by Acquiror and the Stockholder Representative prior to  the  date hereof,
to Acquiror certifying as to the accuracy and completeness of  the 
information provided pursuant to this _Section  3.1(h)_.

 

 

Section  3.2 _Payment  for Shares, Warrants and Company Stock Options_.

 

 

(a) _Paying  Agent_.  No  later than 3 Business Days prior to the Effective
Time, Acquiror shall designate  a bank or trust company reasonably acceptable
to the Company to act as paying  agent in connection with the Merger (the "
_Paying  Agent_ ")  pursuant to a paying agent agreement providing for,
among other things, the  matters set forth in this _Section  3.2_.  At
the  Effective Time, Acquiror shall deposit with the Paying Agent, for the
benefit  of  holders of Shares and Warrants (other than the Wire Transfer
Recipients), cash  (the " _Payment  Fund_ ")  in an  amount sufficient to
pay the Per Share Merger Consideration for all outstanding  shares of Common
Stock, the Preferred Purchase Price for all outstanding shares  of Preferred
Stock and the amount to be paid pursuant to _Section  3.1(f)_   for all 
outstanding Warrants (other than the Shares and Warrants held by the Wire 
Transfer Recipients). If for any reason the Payment Fund is inadequate to
pay  the amounts to which Stockholders and holders of Warrants are entitled 


 

 

 

 

 

 

 

11  

 

 

 

 

 

 

pursuant  to this _Section  3.2_ ,  Acquiror shall be liable for the
payment thereof. Acquiror or the Surviving  Corporation shall pay the
expenses of the Paying Agent.

 

 

(b) _Investment  of Payment Fund_.  The  Paying Agent shall invest any cash
included in the Payment Fund as directed  by  Acquiror or, after the
Effective Time, the Surviving Corporation, in:  (i) direct obligations of, or
obligations the principal of and interest on  which are unconditionally
guaranteed by, the United States of America with  a  remaining term at the
time of acquisition thereof not in excess of 90 days,  (ii) money market
accounts or certificates of deposit maturing within 90  days of the
acquisition thereof and issued by a bank or trust company organized  under
the laws of the United States of America or a state thereof and having  a 
combined capital surplus in excess of $500,000,000 or (iii) commercial  paper
issued by a domestic corporation and given a rating of no lower than  A-1 
by Standard and Poor\'s Corporation or P-1 by Moody\'s Investors  Service, Inc.
Any interest and other income resulting from such investments  shall be paid
as directed by Acquiror or, after the Effective Time, the  Surviving
Corporation. To the extent that there are losses with respect to  such 
investments, or the Payment Fund diminishes for other reasons below the
level  required to make prompt payments of the then remaining amounts to be
paid from  the Payment Fund as contemplated hereby, Acquiror shall promptly
replace or  restore the portion of the Payment Fund lost through investments
or other events  so as to ensure that the Payment Fund is, at all times,
maintained at a level  sufficient to make such payments.

 

 

(c) _Notice  of Exchange_.  Promptly after the Effective Time, the Surviving
Corporation shall cause the  Paying Agent to mail to each holder of record
(other than the Wire Transfer  Recipients) as of the Effective Time, of any
outstanding certificate or  certificates that, immediately prior to the
Effective Time, evidenced  outstanding Shares and Warrants (the "
_Certificates_ "),  a  form letter of transmittal (which shall specify that
delivery shall be effected,  and risk of loss and title to the Certificates
shall pass, only upon proper  delivery of the Certificates to the Paying
Agent) (a " _Letter  of Transmittal_ ")  and  instructions for use in
effecting the surrender of the Certificates in exchange  for payment
therefor.

 

 

(d) _Payment  by Paying Agent_.  Upon  the surrender of a Certificate for
cancellation to the Paying Agent, together  with the Letter of Transmittal
related thereto duly executed, the holder of  such  Certificate shall be
entitled to receive in exchange therefor, promptly and  in  no event more
than 30 days after such surrender, an amount in cash equal to  (i) in the
case of Common Stock, the product of (A) the number of  shares of Common
Stock held by such holder and (B) the Per Share Merger  Consideration, (ii)
in the case of Preferred Stock, the consideration described  in _Section 
3.1(g)_ and  (iii) in the case of Warrants, the consideration described in
_Section 3.1(f)_.  Until  surrendered in accordance with the provisions of
this _Section 3.2_,  any  Certificate (other than Certificates representing
Shares described in  _Sections 3.1(b)_  and  _(d)_   and any  Dissenting
Shares) shall be deemed, at any time after the Effective Time, to  represent
only the right to receive the portion of the Total Merger Payment  payable
with respect thereto, in cash, without interest, as contemplated  herein.

 

 

(e) _Payment  to Wire Transfer Recipients_.  On the  Closing Date, Acquiror
shall pay, or cause MergerCo to pay, to the Wire Transfer  Recipients the
portion of the Total Merger Payment payable to such Wire Transfer  Recipients
by wire transfer of immediately available funds to the respective  bank
accounts designated by such Wire Transfer Recipients by


 

 

 

 

 

 

 

12  

 

 

 

 

 

 

written  notice to Acquiror and the Company at least 3 Business Days prior to
the Closing  Date ( _provided_   that  Certificates issued in the name of
such Wire Transfer Recipients and  representing the Shares and Warrants held
by such Wire Transfer Recipients  have  been submitted to the Company to the
reasonable satisfaction of Acquiror at  least 3 Business Days prior to the
Closing Date for cancellation at the  Effective Time).

 

 

(f) _Payment  to Holders of Company Stock Options_.  Acquiror shall, at or
prior to the Effective Time, deposit the portion of the  Total Merger Payment
attributable to the Company Stock Options, by wire transfer  of immediately
available funds, with the Company, for the benefit of the holders  of Company
Stock Options. Promptly following the Effective Time, the Company  shall pay
to holders of Company Stock Options the amounts set forth in  _Section
3.1(f)_.

 

 

(g) _No  Further Ownership Rights in Shares_.  The  cash paid to the
holders of Shares, Warrants and Company Stock Options in  accordance with the
terms of this _Article III_  shall be  deemed to have been paid in full
satisfaction of all rights pertaining to such  Shares, Warrants and Company
Stock Options, and there shall be no further  registration of transfers on
the stock transfer books of the Surviving  Corporation of the Shares,
Warrants or Company Stock Options which were  outstanding immediately prior
to the Effective Time. If, after the Effective  Time, Certificates are
presented to the Surviving Corporation for any reason,  they shall be
cancelled and exchanged as provided in this _Article III_.  Until 
surrendered in accordance with the provisions of this _Section 3.2_,  each 
Certificate (other than Certificates representing any Shares described in 
_Sections  3.1(b)_   and  _(d)_   and any  Dissenting Shares) shall
represent for all purposes only the right to receive  the consideration
described in _Section 3.1_  applicable thereto, without any interest thereon,
subject to any Taxes deducted  or withheld pursuant to _Section 3.2(l)_. 

 

 

(h) _Transfers  of Ownership_.  In the  event of a transfer of ownership of
Shares or Warrants that is not registered  in  the transfer records of the
Company, payment of the consideration described  in  _Section 3.1_ 
applicable thereto may be made to a transferee if the Certificate with
respect  thereto is presented to the Paying Agent or Acquiror, as applicable,
properly  endorsed and accompanied by all documents required to evidence and
effect such  transfer and by evidence that any applicable stock transfer
taxes have been  paid.

 

 

(i) _Lost,  Stolen and Destroyed Certificates_.  If any  Certificate shall
have been lost, stolen or destroyed, upon the making of an  affidavit of that
fact by the holder thereof, the Paying Agent or Acquiror,  as  applicable,
shall pay in exchange for such lost, stolen or destroyed Certificate  the
relevant portion of the Total Merger Payment payable in respect thereof 
pursuant to this _Section 3.2_  for  Shares represented thereby; _provided_
,  _however_ ,  that  the Surviving Corporation or the Paying Agent may, in
their discretion, require  the delivery of a satisfactory indemnity.

 

 

(j) _Termination  of Payment Fund_.  Any  portion of the Payment Fund that
remains undistributed to the holders of the  Shares or Warrants for 6 months
after the Effective Time shall be delivered  to  the Surviving Corporation
on demand. Any holders of Shares or Warrants prior  to  the Merger who have
not exchanged all of their Shares or Warrants, as  applicable, in accordance
with _Articles II_  and  _III_   prior to  that time shall thereafter look
only to


 

 

 

 

 

 

 

13  

 

 

 

 

 

 

the  Surviving Corporation and only as general creditors thereof with respect
to  any  portion of the Merger Consideration payable in respect thereof,
without  interest.

 

 

(k) _No  Liability_.  None of  the Paying Agent, Acquiror, MergerCo or the
Surviving Corporation shall be  liable to any holder of a Certificate for any
amount properly delivered to  a  public official pursuant to any applicable
abandoned property, escheat or  similar law.

 

 

(l) _Withholding  Rights_.  Each of  Acquiror, the Surviving Corporation
and the Paying Agent shall be entitled  to  deduct and withhold from any
consideration otherwise payable to any Person  pursuant to this Agreement
such amounts as it is required to deduct and withhold  with respect to the
making of such payment under the Code, or any provision  of  applicable Tax
Law. To the extent that such amounts are so withheld or paid  over  to or
deposited with the relevant Governmental Authority by Acquiror, the 
Surviving Corporation or the Paying Agent, such withheld amounts shall be 
treated for all purposes of this Agreement as having been paid to the
applicable  Person in respect to which such deduction and withholding was
made.

 

 

Section  3.3 _Stockholder  Representative_.

 

 

(a) Immediately  upon obtaining the Company Stockholder Approval, each
Stockholder shall be  deemed to have consented to the appointment of
Investcorp Investment Equity  Limited as such Stockholder\'s representative
and attorney-in-fact (the  " _Stockholder  Representative_ "),  with  full
power of substitution to execute any and all instruments or other documents 
on behalf of the Stockholders and to do any and all other acts or things on 
behalf of the Stockholders that the Stockholder Representative may deem 
necessary or advisable, or that may be required pursuant to this Agreement 
or  otherwise, in connection with the consummation of the transactions
contemplated  hereby and the performance of all obligations hereunder at or
following the  Closing. All decisions, actions, consents and instructions by
the Stockholder  Representative shall be binding upon all of the
Stockholders, and no Stockholder  shall have the right to object to, dissent
from, protest or otherwise contest  the same. Acquiror shall not have the
right to object to, dissent from, protest  or otherwise contest the authority
of the Stockholder Representative. Acquiror  and MergerCo shall be entitled
to rely on any decision, action, consent or  instruction of the Stockholder
Representative as being the decision, action,  consent or instruction of the
Stockholders, and Acquiror and MergerCo are hereby  relieved from any
liability to any Person for acts done by them in accordance  with any such
decision, act, consent or instruction. By their approval of this  Agreement,
the Stockholders shall be deemed to have waived any claims they  may  have
or assert, including those that may arise in the future, against the 
Stockholder Representative for any action or inaction taken or not taken by 
the  Stockholder Representative in connection with such Person\'s capacity
as  Stockholder Representative except to the extent that such action or
inaction  shall have been held by a court of competent jurisdiction to
constitute gross  negligence or willful misconduct.

 

 

(b) The  Stockholder Representative may resign at any time, and may be
removed for any  reason or no reason by the vote or written consent of
Stockholders holding  a  majority of the aggregate Fully Diluted Shares at
the Effective Time (the " _Majority  Holders_ ").  In  the event of the
death, incapacity, resignation or removal of the Stockholder  Representative,
a new Stockholder Representative shall be appointed by the  vote  or written
consent of the Majority


 

 

 

 

 

 

 

14  

 

 

 

 

 

 

Holders.  Notice of such vote or a copy of the written consent appointing
such new  Stockholder Representative shall be sent to Acquiror and, after the
Effective  Time, to the Surviving Corporation, such appointment to be
effective upon the  later of the date indicated in such consent or the date
such consent is received  by Acquiror and, after the Effective Time, the
Surviving Corporation. 

 

 

(c) The  approval of this Agreement by the requisite vote or written consent
of  Stockholders shall also be deemed to constitute approval of all
arrangements  relating to the transactions contemplated hereby and to the
provisions hereof  binding upon the Stockholders.

 

 

**ARTICLE  IV**

 

**REPRESENTATIONS  AND WARRANTIES**

 

**OF  THE COMPANY**

 

 

Except  as  set forth in the Disclosure Schedules attached hereto
(collectively, the  " _Disclosure  Schedules_ ")  and  subject to
_Section  9.11_ ,  the  Company hereby represents and warrants to Acquiror
and MergerCo as  follows:

 

 

Section  4.1 _Organization  and Qualification_.

 

 

(a) Each  of  the Company and its Subsidiaries is a corporation, limited
liability company,  trust or limited partnership, as applicable, duly
organized and in good standing  under the laws of the jurisdiction of its
incorporation, organization or  formation, as applicable, as set forth on
_Schedule 4.1(a)  of the Disclosure Schedules_,  and has  all necessary
corporate power and authority to own, lease and operate its  properties and
to carry on its business as it is now being conducted. Each  of  the Company
and its Subsidiaries is duly qualified as a foreign corporation,  limited
liability company, trust or limited partnership, as applicable, and  is  in
good standing, in each other jurisdiction in which ownership, leasing or 
operation of its properties or assets or the conduct of its business
requires  such qualification, except for any such failures that would not
reasonably  be  expected to have a Material Adverse Effect.  Each of  the
Subsidiaries of the Company is wholly-owned by the Company and/or by one 
or  more other Subsidiaries of the Company.

 

 

(b) The  Company has heretofore furnished to Acquiror a complete and correct
copy of  the  certificate of incorporation and bylaws or equivalent
organizational documents,  each as amended to date, of the Company and each
of its Subsidiaries. Such  certificates of incorporation, bylaws or
equivalent organizational documents  are  in full force and effect.

 

 

Section  4.2 _Authority_.

 

 

(a) The  Company has full corporate power and authority to execute and
deliver this  Agreement and, subject to obtaining approval of Stockholders
representing a  majority of the outstanding Shares and, with respect to the
COD Amendment,  the  approval of Stockholders representing a majority of the
outstanding Preferred  Stock (collectively, the " _Company  Stockholder
Approval_ "),  to  perform its obligations hereunder and to consummate the
transactions  contemplated hereby. The execution and delivery by the Company
of this Agreement  and the consummation by the Company of the transactions
contemplated hereby  have  been duly and validly authorized by the Board of
Directors of the Company.  Except for


 

 

 

 

 

 

 

15  

 

 

 

 

 

 

obtaining  the Company Stockholder Approval, no other corporate proceedings
on the part  of  the Company are necessary to authorize the execution and
delivery of this  Agreement or to consummate the transactions contemplated
hereby. This Agreement  has been duly executed and delivered by the Company
and constitutes the legal,  valid and binding obligation of the Company,
enforceable against the Company  in  accordance with its terms, except as
enforcement may be limited by applicable  bankruptcy, insolvency,
reorganization, moratorium or similar laws affecting  creditors\' rights
generally and by general principles of equity (regardless  of  whether
considered in a proceeding in equity or at law).

 

 

(b) The  Board  of Directors of the Company, by unanimous written consent on
October 19, 2006,  (i) determined that this Agreement and the Merger are fair
to and in the best  interests of the Company and its stockholders and (ii)
resolved to recommend  that the Company\'s stockholders approve and adopt
this Agreement and the  Merger.

 

 

Section  4.3 _No  Conflict; Required Filings and Consents_.

 

 

(a) Neither  the execution and delivery by the Company of this Agreement nor
the consummation  of the transactions contemplated hereby will: (i) conflict
with or violate  the  Certificate of Incorporation or Bylaws; (ii) conflict
with or violate in any  material respect any Law applicable to the Company or
by which any property  or  asset of the Company is bound or affected; (iii)
conflict with, violate or  result in the suspension or cancellation of any
material Permit necessary for  each of the Company and its Subsidiaries to
own, lease and operate its  properties and to carry on its business as
currently conducted; or (iv) conflict  with, result in any breach of,
constitute a default (or an event that, with  notice or lapse of time or
both, would become a default) under, result in the  creation of any
Encumbrance under, result in the loss of any material benefit  under or the
acceleration of any rights under or require any consent of any  Person
pursuant to, any Material Contract or any lease with respect to any  Leased
Real Property that is material to the Company and its  Subsidiaries.

 

 

(b) The  Company is not required to file, seek or obtain any material
notice,  authorization, approval, order, permit or consent of or with any
Governmental  Authority in connection with the execution, delivery and
performance by the  Company of this Agreement or the consummation of the
transactions contemplated  hereby, except for (i) any filings required to be
made under the  Hart-Scott-Rodino Antitrust Improvements Act of 1976, as
amended (the  " _HSR  Act_ "),  (ii) the filing of the Certificate of
Merger with the Secretary of State of  the State of Delaware, (iii) such
filings as may be required by any  applicable federal or state securities or
"blue sky" laws and (iv) as may be  necessary as a result of any facts or
circumstances relating specifically to  Acquiror or any of its Affiliates.

 

 

Section  4.4 _Capitalizati_ _on_.  The  Company\'s authorized and
outstanding capital stock is as set forth on  _Schedule  4.4 of the
Disclosure Schedules_.  All of  the Shares are validly issued, fully paid
and nonassessable. _Schedule  4.4 of the Disclosure Schedules_   sets 
forth a complete and accurate list of all holders of Shares, Warrants and 
Company Stock Options and the number of Shares, Warrants and Company Stock 
Options held by each such holder. There are no outstanding obligations,
options,  warrants, convertible securities or other rights, agreements,
arrangements  or  commitments obligating the Company to issue or sell any
shares of capital stock  of, or any other interest in, the Company. There are
no outstanding contractual 

 

 

 

 

 

 

 

16  

 

 

 

 

 

 

obligations  of the Company to repurchase, redeem or otherwise acquire any
shares of capital  stock of the Company or to provide funds to, or make any
investment in, any  other Person. There are no agreements in effect with
respect to the voting  or  transfer of any of the capital stock of the
Company.

 

 

Section  4.5 _Equity  Interests_.  Neither  the Company nor any of its
Subsidiaries, directly or indirectly, owns any  equity, partnership,
membership or similar interest in, or any interest  convertible into,
exercisable for the purchase of or exchangeable for any such  equity,
partnership, membership or similar interest in, any Person. Neither  the 
Company nor any of its Subsidiaries has agreed or is obligated to make or is 
bound by any written or oral agreement, contract, lease, instrument, note, 
option, license, commitment or undertaking of any nature under which it is 
or  may become obligated to make any future investment in or capital
contribution  to  any other Person.

 

 

Section  4.6 _Financial  Statements_ _;  No  Undisclosed Liabilities_.

 

 

(a) The  Company has delivered to Acquiror copies of the audited consolidated
balance  sheet of the Company and its Subsidiaries as at December 31, 2003,
2004 and  2005, and the related audited consolidated statements of
operations, changes  in  stockholders\' equity and cash flows of the Company
and its Subsidiaries,  together with all related notes and schedules thereto,
accompanied by the  reports thereon of the Company\'s independent auditors
(collectively referred  to  as the " _Financial  Statements_ ")  and  the
unaudited consolidated balance sheet of the Company and its Subsidiaries 
as  at June 30, 2006 (the " _Balance  Sheet_ "),  and  the related
consolidated statements of operations, changes in stockholders\'  equity and
cash flows of the Company and its Subsidiaries, together with all  related
notes and schedules thereto (collectively referred to as the  " _Interim 
Financial Statements_ ").  Each  of the Financial Statements and the Interim
Financial Statements (i) has been  prepared based on the books and records of
the Company and its Subsidiaries  (except as may be indicated in the notes
thereto), (ii) has been prepared in  accordance with GAAP applied on a
consistent basis throughout the periods  indicated (except as may be
indicated in the notes thereto) and (iii) fairly  presents, in all material
respects, the consolidated financial position, results  of operations and
cash flows of the Company and its Subsidiaries as at the  respective dates
thereof and for the respective periods indicated therein,  except as
otherwise noted therein and subject, in the case of the Interim  Financial
Statements, to the absence of notes and normal and recurring year-end 
adjustments that will not, individually or in the aggregate, be  material.

 

 

(b) There  are  no debts, liabilities or obligations, whether accrued or
fixed, absolute or  contingent, matured or unmatured or determined or
determinable, of the Company  or any of its Subsidiaries of a nature required
to be reflected on a balance  sheet prepared in accordance with GAAP, other
than any such debts, liabilities  or obligations (i) reflected or reserved 
against on the Interim Financial Statements or the notes thereto or  (ii)
incurred since the date of the Balance Sheet in the ordinary course of 
business of the Company and its Subsidiaries. 

 

 

 

 

 

 

 

17  

 

 

 

 

 

 

  Section 4.7 _Absence  of Certain Changes or Events_.

 

 

(a) Since  December 31, 2005, the Company and its Subsidiaries have conducted
their  business in the ordinary course consistent with past practice, and
neither  the  Company nor any of its Subsidiaries has:

 

 

(i) declared,  set aside, made or paid any dividends or other distributions
(whether in cash,  stock, property or otherwise) with respect to any of its
capital stock, except  for dividends, distributions or other payments made by
any direct or indirect  wholly-owned Subsidiary of the Company to any other
Subsidiary of the Company  and except for dividends of additional shares of
Preferred Stock with respect  to  the Preferred Stock as required pursuant
to the terms of the Certificate of  Designations;

 

 

(ii) acquired,  or disposed of, stock or other securities or assets of any
Person, except in  connection with acquisitions or dispositions of inventory
or equipment in the  ordinary course of business consistent with past
practice;

 

 

(iii) granted  or announced any increase in the salaries, bonuses or other
benefits payable  by  the Company or any of its Subsidiaries to any of their
employees, other than  as  required by Law or other increases consistent
with the past practices of the  Company or such Subsidiary;

 

 

(iv) made  any  change in any method of accounting or accounting practice or
policy, except  as  required by applicable Law or GAAP;

 

 

(v) made  any  material tax election or settled or compromised any United
States federal,  state, local or non-United States income tax liability;

 

 

(vi) commenced  or settled any material Action; or

 

 

(vii) committed,  authorized or agreed to do any of the foregoing.

 

 

(b) Since  December 31, 2005, there has not occurred any event or
circumstance that has  caused or would reasonably be expected to cause a
Material Adverse  Effect.

 

 

Section  4.8 _Compliance  with Law; Permits_.

 

 

(a) Each  of  the Company and its Subsidiaries is in compliance in all
material respects  with  all applicable Laws. Since January 1, 2004, none of
the Company or any of its  Subsidiaries has received written or oral notice
from any Governmental Authority  alleging that the Company or any of its
Subsidiaries has not complied in any  material respect with any Law
applicable to the Company or any of its  Subsidiaries.  

 

(b) (i)  Each  of the Company and its Subsidiaries is in possession of all
Permits granted  by  any health care regulatory agency or other Governmental
Authority (including  any  Governmental Authority having jurisdiction over
the accreditation,  certification, licensing, evaluation or operation of any
of the facilities  or  services of the Company) required for

 


 

 

 

 

 

 

 

18  

 

 

 

 

 

 

the  provision of health care services by the Company or its Subsidiaries
and/or  the  reimbursement of health care costs relating thereto ("
_Health  Care Licenses_ ")  necessary for the Company and its Subsidiaries
to operate the businesses  conducted by the Company and its Subsidiaries as
currently conducted (the  " _Company  Health Care Licenses_ "). 
_Schedule  4.8(b) of the Disclosure Schedules_   sets  forth a true and
correct list of the Company Health Care Licenses. All Company  Health Care
Licenses (x) are valid and in full force and effect, and (y) are  in  good
standing in each jurisdiction in which such Company Health Care Licenses 
were issued or are required for the operation of the business of the Company 
in  compliance with applicable Laws. The Company is not party or subject to
any  judgment, order, decree, injunction, ruling or assessment (" _Order_
")  or  Action with respect to any Company Health Care License. The Company
has not  received notice of any Order or Action pending or recommended by
any  Governmental Authority (or, in the case of accreditation, any
accreditation  body) having jurisdiction over any Company Health Care License
to revoke,  withdraw, suspend, limit, restrict or impair any Company Health
Care License.  No  event has occurred which, with or without the giving of
notice, the passage  of  time, or both, would (A) constitute grounds for a
material violation or order  with respect to any Company Health Care License;
(B) be reasonably likely to  result in the revocation, withdrawal or
suspension of any Company Health Care  License; (C) result in any material
fines, penalties or sanctions against the  Company; (D) give rise to any
material obligation on the part of the Company  to  undertake, or to bear
all or any portion of the cost or, any remedial action  of  any nature
(other than the cure of deficiencies in the ordinary course of  business); or
(E) result in the imposition of any Encumbrance against the  Company or any
of its properties under any Company Health Care License, and  the  Company
has received no notice of any of the foregoing.

 

 

(ii) Each  of  the Company and its Subsidiaries is in possession of all
Permits, other than  Health Care Licenses, necessary for each of the Company
and its Subsidiaries  to  own, lease and operate its properties and to carry
on its business as currently  conducted, except where the failure to have, or
the suspension or cancellation  of, any of such Permits would not,
individually or in the aggregate, reasonably  be expected to have a Material
Adverse Effect.

 

 

Section  4.9 _Litigation_.  There  is no Action by or against the Company
or any of its Subsidiaries pending or,  to  the Knowledge of the Company,
threatened that would reasonably be expected  to  result in losses, costs
and expenses to the Company and its Subsidiaries in  excess of $500,000 or
limit or restrict in any material respect the operation  of  the business of
the Company and its Subsidiaries as presently  conducted.

 

 

Section  4.10 _Employee  Benefit Plans_.

 

 

(a) _Schedule  4.10(a) of the Disclosure Schedules_   sets  forth (i) a
list of all material employee benefit plans (as defined in Section  3(3) of
the Employee Retirement Income Security Act of 1974, as amended  (" _ERISA_
"))  and  all bonus, stock option, stock purchase, restricted stock,
incentive, deferred  compensation, retiree medical or life insurance,
supplemental retirement,  severance or other benefit plans, programs or
arrangements, that are maintained,  contributed to or sponsored by the
Company or any of its Subsidiaries for the  benefit of any current or former
employee, officer or director of the Company  or  any of its Subsidiaries,
or under which the Company or any of its Subsidiaries  has or is reasonably
expected to have any present or future liability (directly  or indirectly),
(ii) a list of all material employment,


 

 

 

 

 

 

 

19  

 

 

 

 

 

 

termination,  severance or other contracts, agreements or arrangements,
pursuant to which  the  Company or any of its Subsidiaries currently has any
obligation with respect  to  any current or former employee, officer or
director of the Company or any of  its  Subsidiaries and (iii) a list of all
Employee Merger Payments, and the type  and  amount of the Employee Merger
Payments with respect to each recipient or  potential recipient of an
Employee Merger Payment (collectively, the  " _Employee  Plans_ ").  The 
Company has made available to Acquiror, with respect to each Employee Plan, 
a  true and complete copy of (where applicable) each Employee Plan, all
current  summary plan descriptions, the three most recently filed Form 5500s,
the most  recent determination or opinion letter from the IRS, all material
correspondence  to or from any Governmental Authority received in the last
three years, all  discrimination tests for the most recent three plan years,
and all material  written agreements and contracts currently in effect,
including (without  limitation) administrative service agreements, group
annuity contracts, and  group insurance contracts.

 

 

(b) (i)  Each  Employee Plan has been maintained in all material respects in
accordance with  its terms and the requirements of applicable Law, including
ERISA and the Code,  (ii) each of the Company and its Subsidiaries has
performed all material  obligations required to be performed by it under any
Employee Plan and is not  in  any material respect in default under or in
violation of any Employee Plan  and  (iii) no Action (other than claims for
benefits in the ordinary course) is  pending or threatened in writing with
respect to any Employee Plan and, to  the  Knowledge of the Company, no
facts or conditions exist that would reasonably  be  expected to result in
such an Action. Neither the Company nor any of its  Subsidiaries is subject
to any material liability or penalty under Sections  4975  through 4980B of
the Code or Title I of ERISA. The Company and its Subsidiaries  have complied
in all material respects with all applicable health care  continuation
requirements in Section 4980B of the Code and in ERISA. No  "Prohibited
Transaction," within the meaning of Section 4975 of the Code or  Sections 406
or 407 of ERISA and not otherwise exempt under Section 408 of  ERISA, has
occurred with respect to any Benefit Plan that would reasonably  be 
expected to result in a material liability for the Company or its 
Subsidiaries.

 

 

(c) Each  Employee Plan that is intended to be qualified under Section 401(a)
of the  Code  has received a determination or opinion letter from the IRS
that it is so  qualified and each related trust that is intended to be exempt
from federal  income taxation under Section 501(a) of the Code has received
a  determination or opinion letter from the IRS that it is so exempt and, to
the  Knowledge of the Company, no fact or event has occurred since the date
of such  letter or letters from the IRS that would reasonably be expected to
result  in  the loss of the qualified status of any such Employee Plan or
the exempt status  of any such trust.

 

 

(d) None  of  the Employee Plans is a multiemployer plan (within the meaning
of Section 3(37)  or 4001(a)(3) of ERISA) or a single employer plan (within
the meaning of Section  4001(a)(15) of ERISA) for which the Company or any of
its Subsidiaries would  reasonably  be expected to incur liability under
Section 4063 or 4064 of ERISA, including  any liability that could be imposed
if the Company were to fully or partially  withdraw from such Employee Plan.
 

 

(e) Neither  the Company nor any of its Subsidiaries is a party to any
contract, agreement  or  arrangement that could, directly or in combination
with other events, including  the

 


 

 

 

 

 

 

 

20  

 

 

 

 

 

 

transactions  contemplated by this Agreement, result, separately or in the
aggregate, in  the  payment, acceleration or enhancement of any benefit to
any current or former  employee or director that would be considered an
"excess parachute payment"  within the meaning of Section 280G of the Code.

 

 

(f) No  Employee Plan provides or reflects or represents any liability to
provide  welfare benefits (including, without limitation, death or medical
benefits),  whether or not insured, with respect to any former or current
employee, or  any  spouse or dependent of any such employee, beyond the
employee\'s retirement  or  other termination of employment with the Company
and its Subsidiaries other  than  (i) coverage mandated by Part 6 of Title I
of ERISA or Section 4980B of the  Code  or (ii) long-term disability
benefits that have been fully provided for by  insurance under a Benefit Plan
that constitutes an "employee welfare benefit  plan" within the meaning of
Section (3)(1) of ERISA.

 

 

(g) Except  for benefits determined pursuant to the terms of the Supplemental
Executive  Retirement Plan specifically identified on _Section  4.10(g) of
the Disclosure Schedules_   (the  " _SERP_ "),  the  Company and its
Subsidiaries have no liability or contingent liability under  a 
"nonqualified deferred compensation plan," as defined in Code Section 
409A(d)(1). The Company has established a grantor trust (the " _Rabbi  Trust_
")  to  hold assets for the payment of benefits under the SERP. Except in
the event  of  the Company\'s insolvency, all assets of the Rabbi Trust may
only be used for  the  payment of benefits under the SERP. All contributions
for benefits earned under  the SERP have been made in full to the Rabbi
Trust. No participant or  beneficiary of the SERP may become entitled to any
benefit under the SERP in  excess of the assets of the Rabbi Trust
attributable to such participant or  beneficiary, and the aggregate benefits
of all participants and beneficiaries  under the SERP do not exceed the
assets of the Rabbi Trust.

 

 

Section  4.11 _Labor  and Employment Matters_.

 

 

(a) Neither  the Company nor any of its Subsidiaries is a party to any labor
or collective  bargaining contract that pertains to employees of the Company
or any of its  Subsidiaries. Since January 1, 2004, no labor union or
organization has filed  a  petition with the National Labor Relations Board
or any other Governmental  Authority seeking certification as the collective
bargaining representative  of  any employee of the Company or any of its
Subsidiaries. There are no pending,  or  to the Knowledge of the Company,
threatened Actions concerning labor or  employment Law matters with respect
to the Company or any of its Subsidiaries,  including but not limited to any
(i) strike, lockout, material slowdown or  material work stoppage with
respect to any employees of the Company or any  of  its Subsidiaries, (ii)
material unfair labor practice charge, grievance or  complaint filed or
pending against the Company or any of its Subsidiaries,  or  (iii) material
Action in which the Company or any of its Subsidiaries is alleged  to  have
violated any Laws relating to employment, equal opportunity,  discrimination,
harassment, retaliation, immigration, wages, hours, benefits,  collective
bargaining, the payment of social security and similar taxes and/or  privacy
rights of employees.  

 

(b) Neither  the Company nor any of its Subsidiaries is subject to, nor, to
the Knowledge  of  the Company, is there any reasonable expectation that the
Company or any  of its  Subsidiaries will be subject to, any material
liability with respect to any  misclassification of any

 


 

 

 

 

 

 

 

21  

 

 

 

 

 

 

person  as  (i) an independent contractor rather than as an employee, or
with respect to  any  employee leased from another employer, or (ii) an
employee exempt from state  or  federal overtime regulations.

 

 

(c) Since  January 1, 2004, neither the Company nor any Subsidiary has
effectuated  (i) a "plant closing" (as defined in the Worker Adjustment and
Retraining  Notification Act (the " _WARN  Act_ ")  or any  similar state,
local or foreign Law) affecting any site of employment or one  or  more
facilities or operating units within any site of employment or facility  of 
the Company or any Subsidiary or (ii) a "mass layoff" (as defined in the 
WARN Act (or any similar state, local or foreign Law)) affecting any site of 
employment or facility of the Company or any Subsidiary, except in each case 
that all material liabilities under the WARN Act have been  satisfied.

 

 

Section  4.12 _Insurance_.  _Schedule  4.12 of the Disclosure Schedules_  
sets  forth a true and complete list of all material insurance policies in
force  with  respect to the Company and its Subsidiaries. All such policies
are in full  force  and effect and, to the Knowledge of the Company, no
event has occurred that  would, by the terms of the policy, reasonably be
expected to give any insurance  carrier a right to terminate any such policy
prior to its  expiration.

 

 

(b) _Schedule  4.12(b) of the Disclosure Schedules_ sets  forth a true and
complete list, in all material respects, of all claim activity  from June 30,
2001 through March 31, 2006, both open and closed, under the  general and
professional liability policies maintained by the Company and its 
Subsidiaries and all claim activity from June 30, 2001 through June 30,
2006,  both open and closed, under the workers\' compensation policies
maintained by  the  Company and its Subsidiaries.

 

 

Section  4.13 _Real  Property_.

 

 

(a) _Schedule  4.13(a) of the Disclosure Schedules_   contains  a true,
complete and correct list of (i) the street addresses for each parcel  of 
Owned Real Property and (ii) the current owner(s) of each parcel of Owned
Real  Property. The Company or its Subsidiaries have good and marketable fee
simple  title to each parcel of Owned Real Property, free and clear of all
Encumbrances,  other than Permitted Encumbrances. There are no leases,
subleases, licenses,  concessions, or other agreements that are material to
the Company and its  Subsidiaries granting to any Person besides the Company
and its Subsidiaries  the  right of use or occupancy of any portion of the
Owned Real Property.  The  Company and its Subsidiaries have made available
to Acquiror a true, correct  and  complete copies of each deed for each
parcel of Owned Real Property and the  title insurance policies, title
reports and surveys relating to each parcel  of  the Owned  Real Property,
together with all addenda, modifications, and amendments thereto,  in each
case in the possession of the Company or any of its  Subsidiaries. 

 

(b) _Schedule  4.13(b) of the Disclosure Schedules_   contains  a true,
complete and correct list of (i) the street addresses for each parcel  of 
Leased Real Property and (ii) the identity of the lessor, lessee and current 
occupant (if different from lessee) of each such parcel of Leased Real
Property.  Each Leased Real Property is free and clear of all Encumbrances,
other than  Permitted Encumbrances and any such exceptions that would not,
individually  or  in the aggregate, reasonably be expected to have a
Material Adverse Effect.  Each  lease and sublease

 


 

 

 

 

 

 

 

22  

 

 

 

 

 

 

relating  to the Leased Real Property is legal, valid, binding, enforceable
and in full  force and effect in all material respects. To the Knowledge of
the Company,  the  Company and its Subsidiaries are not in default in any
material respect under  any such lease or sublease and there exists no event
of default or event,  occurrence, condition or act which, with the giving of
notice or lapse of time,  would become a default under any such lease or
sublease beyond any applicable  notice or cure period. The Company and its
Subsidiaries have made available  to  Acquiror true, correct and complete
copies of the leases and subleases  (including ground leases, if any)
relating to all of the Leased Real Property,  together with all addenda,
modifications, and amendments thereto, in each case  in the possession of the
Company or any of its Subsidiaries.

 

 

(c) The  Company and its Subsidiaries have not granted and, to the Knowledge
of the  Company, there are currently no outstanding options or rights of
first refusal  of any third party to purchase or lease the Owned Real
Property, or any portion  thereof or interest therein.

 

 

(d) There  are  no (i) pending or, to the Knowledge of the Company
threatened condemnation  proceedings by any Governmental Authority relating
to any portion of the Real  Property; (ii) material special assessments by
any Governmental Authority  affecting any portion of the Real Property; or
(iii) pending or, to the  Knowledge of the Company, threatened enforcement
proceedings relating to an  alleged zoning violation affecting any portion of
the Real  Property.

 

 

Section  4.14 _Intellectual  Property_.  _Schedule  4.14 of the Disclosure
Schedules_   sets  forth a true and complete list of all patents and patent
applications,  registered trademarks or service marks and applications to
register any  trademarks or service marks, and registered copyrights and
applications for  registration of copyrights owned by the Company or any of
its Subsidiaries  and  used in the Company\'s or any of its Subsidiaries\'
businesses. The Company and  its Subsidiaries own or possess licenses or
other rights to use all Intellectual  Property used in their businesses and
no rights of such Intellectual Property  have been granted to any Person by
the Company or any of its Subsidiaries.  The  use by the Company and each of
its Subsidiaries of their respective Intellectual  Property does not infringe
upon the Intellectual Property of or otherwise  violate the rights of any
Person, except for any such infringements or  violations which, individually
or in the aggregate, would not reasonably be  expected to have a Material
Adverse Effect. To the Knowledge of the Company,  no  claim has been
asserted or threatened that the use or exploitation by the  Company or any of
its Subsidiaries of any Intellectual Property owned by the  Company or any of
its Subsidiaries infringes the Intellectual Property of any  third party.

 

 

Section  4.15 _Taxes_.  All  material Returns required to have been filed
by or with respect to the Company  or its Subsidiaries have been timely filed
(taking into account any extension  of  time to file granted or obtained)
and all such Returns are complete and correct  in all material respects. All
Taxes shown to be payable on such Returns have  been paid or will be timely
paid. No deficiency for any material amount of  Tax  has been asserted or
assessed by a Governmental Authority in writing against  the  Company or any
of its Subsidiaries that has not been satisfied by payment,  settled or
withdrawn. The Company has provided Acquiror with copies of all  extensions
of time filed with respect to all income Returns that are currently  subject
to such extensions. There are no Tax liens on the assets of the Company  or
any of its Subsidiaries (other than Permitted Encumbrances). The Company 
is  not a "United States real property holding corporation" (" _USRPHC_ ") 
within  the meaning of Section 897 of the Code and


 

 

 

 

 

 

 

23  

 

 

 

 

 

 

was  not a  USRPHC on any "determination date" (as defined in Section
1.897-2(c) of the  Treasury Regulations) that occurred in the five-year
period preceding the  Closing Date. Neither the Company nor any of its
Subsidiaries has ever been  a  member of a combined, consolidated,
affiliated or unitary group for Tax filing  purposes, other than the group in
which it currently is a member. The Company  and its Subsidiaries are not,
and have not ever been, a party to any Tax sharing  indemnity or similar
agreement allocating tax liability that will not be  terminated on the
Closing Date without any future liability to the Company  or  any of its
Subsidiaries (including for past Taxes). No material claim has ever  been
made by any Taxing authority in a jurisdiction in which any of the Company 
or its Subsidiaries does not file Returns that any such person is or may be 
subject to Taxation by that jurisdiction, and, to the Knowledge of the
Company,  no basis exists for any such claim to be made. The Company and its
Subsidiaries  have not agreed to, and are not required to, make any
adjustments or changes  either on, before or after the Closing Date, to its
accounting methods pursuant  to Section 481 of the Code (or similar
provisions of state, local or foreign  law), and neither the Internal Revenue
Service nor any other Tax authority  has  proposed any such adjustments or
changes in the accounting methods of the  Company and the Subsidiaries.
Neither the Company nor any of its Subsidiaries  will be required to include
in income during a taxable period that ends after  the Closing Date any
income that economically accrued and was accounted for  prior to the Closing
Date by reason of the installment method of accounting,  the  completed
method of accounting or otherwise. Neither the Company nor any of  its 
Subsidiaries has been a party to a transaction to which Section 355 of the 
Code  applied or was intended to apply, nor was any stock or securities of
the Company  or any of its Subsidiaries distributed in such a transaction.
Neither the  Company nor any of its Subsidiaries has entered into any
transaction identified  as a "listed transaction" for purposes of Treasury
Regulation Sections  1.6011-4(b)(2). The Company has provided Acquiror with
information with respect  to all material direct transfers of equity
interests in the Company after August  1998, and has provided Acquiror with
forms of representation letters with  respect to certain indirect ownership
of the Company\'s equity as of October  20,  2004, and thereafter. The
Company has not received any written notice from  any  taxing authority that
the Company or any of its Subsidiaries is the subject  of  an audit or
examination regarding any material issues regarding  Taxes.

 

 

Section  4.16 _Environmental  Matters_.

 

 

(a)   (i) The  Company and its Subsidiaries are in compliance in all
material respects with  all  applicable Environmental Laws and have obtained
and are in compliance in all  material respects with all Environmental
Permits, (ii) there are no material  Actions or written claims  pursuant to
any Environmental Law pending or threatened in writing against  the  Company
or its Subsidiaries alleging a violation of or liability under, 
Environmental Laws and (iii) there have been no material Releases of
Hazardous  Materials at, on, to, under, or emanating from any Owned Real
Property or Leased  Real Property or, to the Knowledge of the Company, any
property formerly owned  or leased by the Company or its Subsidiaries ("
_Former  Properties_ "),  or to  the Knowledge of the Company, any property
to which Hazardous Materials from  any  Owned Real Property, Leased Real
Property, or Former Property were transported  for treatment, storage,
handling or disposal. 

 

(b) The  Company has provided Acquiror all material environmental,
assessments, reports,  investigations, audits, or studies in its possession
or control relating  to the  Owned Real Property and Leased Real Property.

 


 

 

 

 

 

 

 

24  

 

 

 

 

 

 

  (c) The  representations and warranties contained in this _Section  4.16_
  are the  only representations and warranties being made with respect to
compliance with  or liability under Environmental Laws or with respect to any
environmental,  health or safety matter, including natural resources, related
to the Company  or  its Subsidiaries.

 

 

Section  4.17 _Material  Contracts_.

 

 

(a) _Schedule  4.17(a) of the Disclosure Schedules_   lists  each of the
following contracts and agreements of the Company and its  Subsidiaries (such
contracts and agreements as described in this _Section  4.17(a)_   being  "
_Material  Contracts_ "):

 

 

(i) all  contracts or agreements that provide for payment or receipt by the
Company  or  any of its Subsidiaries of more than $500,000 per year,
including any such  contracts and agreements with customers or clients;

 

 

(ii) all  contracts and agreements relating to indebtedness for borrowed 
money;

 

 

(iii) all  contracts and agreements that limit or purport to limit the
ability of the  Company or any of its Subsidiaries to compete in any line of
business or with  any Person or in any geographic area or during any period
of time;

 

 

(iv) all  material joint venture, partnership or similar agreements or
arrangements; 

 

 

(v) any  guarantee or indemnification agreement;

 

 

(vi) any  agreement with any "business associates" as such term is defined in
the Health  Insurance Portability and Accountability Act of 1996 (" _HIPAA_
");

 

 

(vii) any  Medicaid or Medicare provider agreements;

 

 

(viii) any  agreement, contract or commitment currently in force relating to
the disposition  or acquisition by the Company or any of its Subsidiaries
after the date hereof  of  any assets not in the ordinary course of business
or pursuant to which the  Company or any of its Subsidiaries has any
ownership interest in any  corporation, partnership, joint venture or other
business  enterprise; 

 

(ix) any  settlement agreement that includes continuing obligations or
restrictions  on the  Company or any of its Subsidiaries;

 

 

(x) any  contract, agreement or commitment for capital expenditures having a
remaining  balance in excess of $250,000;

 

 

(xi) any  software licenses that are material to the business and operations
of the  Company and its Subsidiaries, taken as a whole

 


 

 

 

 

 

 

 

25  

 

 

 

 

 

 

 

(xii) any  contract or agreements that will be in full force and effect after
the Closing  between the Company or any of its Subsidiaries, on the one hand,
and (A) any  Affiliate of the Company, (B) any director, officer or employee
of the Company  or its Subsidiaries or (C) any other person not at arm\'s
length to the Company,  on the other hand; and

 

 

(xiii) any  other  contract or agreement that is material to the Company and
its Subsidiaries,  taken as a whole.

 

 

(b) Each  Material Contract is valid and binding, in all material respects,
on the Company  or the applicable Subsidiary, as the case may be, and, to the
Knowledge of  the  Company, the counterparties thereto, and is in full force
and effect in all  material respects. Neither the Company nor any of its
Subsidiaries is in breach  of, or default under, any Material Contract to
which it is a party, except  for  such breaches or defaults that would not,
individually or in the aggregate,  reasonably be expected to have a Material
Adverse Effect.

 

 

Section  4.18 _Brokers_.  Except  for the fees, commissions and expenses
that are included in the Company  Transaction Expenses, the Company will not
be obligated to pay any fee or  commission to any broker, finder or similar
intermediary for or on account  of  the transactions contemplated by this
Agreement.

 

 

Section  4.19 _Indebtedness_.  _Schedule  4.19 of the Disclosure Schedules_
  sets  forth a complete and accurate list, as of the date of this
Agreement, of all  Indebtedness of the Company and its Subsidiaries.

 

 

Section  4.20 _Medicaid/Medicare  Programs_.

 

 

(a) The  Facilities are certified by each applicable Governmental Authority
and any  accrediting and certifying organizations having jurisdiction over
such  Facilities for participation in the Medicare and Medicaid programs, and
each  Facility is in substantial compliance with conditions of participation
of such  programs. Each Facility is a party to valid participation agreements
for  payments by the Medicare and Medicaid programs, which agreements are in
full  force and effect. No Facility has received written notice from any
Governmental  Authority regarding any threatened or existing Action to
terminate, suspend,  revoke or limit any Facility\'s participation in any
Medicare, Medicaid or  TRICARE programs.  

 

(b) None  of  the Company or any of its Subsidiaries, or any of the
Company\'s or its  Subsidiaries\' respective directors, officers has been
convicted of or charged  with a Medicare, Medicaid, other Federal Health Care
Program (as defined  in 42  U.S.C.  1320a-7b(f)), or TRICARE programs
related offense. None of the Company  or any of its Subsidiaries, or, to the
Knowledge of the Company, any of the  Companies\' or its Subsidiaries\'
respective directors, officers or employees  has  been convicted of a
violation of Federal or state law related to fraud, theft,  embezzlement,
breach of fiduciary responsibility or obstruction of an  investigation. None
of the Company or any of its Subsidiaries, or any of  the  Company\'s or its
Subsidiaries\' respective directors, officers, or, to the  Company\'s
Knowledge, employees has been excluded or suspended from participation  in
Medicare, Medicaid or TRICARE programs, or have been debarred, suspended 
or  are otherwise ineligible to participate in Federal  programs.

 


 

 

 

 

 

 

 

26  

 

 

 

 

 

 

 

(c) None  of  the Company or any of its Subsidiaries or any of the
Company\'s or its  Subsidiaries\' respective directors or officers has
directly or indirectly made  any contribution, gift, bribe, rebate, payoff,
influence payment, kickback  or  other payment (other than legal
concessions, travel and entertainment or other  legal items arising in the
ordinary course of business) to any Person,  regardless of form, whether in
money, property or services to (i) obtain  favorable treatment in securing
business, (ii) pay for favorable treatment  for  business secured or (iii)
obtain special concessions or for special concessions  already obtained, for
or in respect of the Company, its Subsidiaries or any  of  their respective
businesses.

 

 

(d) The  Company and each of its Subsidiaries have filed all material claims
or other  material reports required to be filed with respect to the purchase
of services  by third-party payors under Medicare or Medicaid. All such
claims or reports  are  complete and accurate in all material respects.
Neither the Company nor any  of  its Subsidiaries have received any written
notice or, to the Knowledge of the  Company, any oral notice of any material
pending appeals, overpayment  determinations, adjustments, challenges,
audits, litigation, or notices of  intent to reopen any Medicare or Medicaid
claims determinations or other reports  required to be filed by the Company
or any of its Subsidiaries in order to  be  paid by a payor for services
rendered.

 

 

Section  4.21 _HIPAA  Compliance_.  The  Company and its Subsidiaries have
established and implemented such policies,  programs, procedures, contracts
and systems as are necessary to bring the  Company and its Subsidiaries into
compliance with HIPAA; Title II, Subtitle  F,  Sections 261-264, Public Law
104-191; and the Standards for Privacy of  Individually Identifiable Health
Information, 45 C.F.R. Parts 160-164 as of  the  effective dates of such
laws.

 

 

Section  4.22 _Hill-Burton  Act_.  None of  the Company or any of its
Subsidiaries or, to the Knowledge of the Company,  any  previous owner of
the Facilities has received any funding in connection with  the  Facilities
under the federal Hill-Burton Act.

 

 

 

**ARTICLE  V**

 

**REPRESENTATIONS  AND WARRANTIES**

 

**OF  ACQUIROR AND MERGERCO**

 

 

Except  as  set forth in the Acquiror Disclosure Schedules attached hereto
(the  " _Acquiror  Disclosure Schedules_ ")  and  subject to _Section 
9.11_ ,  Acquiror and MergerCo, jointly and severally, hereby represent and
warrant  to  the Company as follows:

 

 

Section  5.1 _Organization_ _  and  Qualification_.

 

 

(a) Each  of  Acquiror and MergerCo (i) is a corporation duly organized,
validly existing  and  in good standing under the laws of its jurisdiction
of incorporation, and  (ii)  has all necessary corporate power and authority
to own, lease and operate  its  properties and to carry on its business as
it is now being conducted. 

 

 

(b) Each  of  Acquiror and MergerCo have heretofore furnished to the Company
complete and  correct copies of its certificate of incorporation and bylaws
as in effect  on  the date hereof and as proposed to be in effect
immediately prior to the  Closing  Date.

 


 

 

 

 

 

 

 

27  

 

 

 

 

 

 

  Section 5.2 _Authority_.  Each of  Acquiror and MergerCo has full
corporate power and authority to execute and  deliver this Agreement, to
perform its obligations hereunder and to consummate  the transactions
contemplated hereby. The execution and delivery by Acquiror  and  MergerCo
of this Agreement and the consummation by Acquiror and MergerCo of  the 
transactions contemplated hereby have been duly and validly authorized by
the  Boards of Directors of Acquiror and MergerCo and by Acquiror as the
sole  stockholder of MergerCo. No other corporate proceedings on the part of
Acquiror  or MergerCo are necessary to authorize this Agreement or to
consummate the  transactions contemplated hereby. This Agreement has been
duly and validly  executed and delivered by Acquiror and MergerCo, as
applicable. This Agreement  constitutes the legal, valid and binding
obligation of Acquiror and MergerCo,  as  applicable, enforceable against
Acquiror and MergerCo, as applicable, in  accordance with its terms, except
as enforcement may be limited by applicable  bankruptcy, insolvency,
reorganization, moratorium or similar laws affecting  creditors\' rights
generally and by general principles of equity (regardless  of  whether
considered in a proceeding in equity or at law).

 

 

Section  5.3 _No  Conflict; Required Filings and Consents_.

 

 

(a) The  execution, delivery and performance by each of Acquiror and MergerCo
of this  Agreement and the consummation of the transactions contemplated
hereby do not  and will not: (i) conflict with or violate the certificate of
incorporation  or  bylaws of Acquiror or MergerCo; (ii) conflict with or
violate any Law applicable  to Acquiror or MergerCo or by which any property
or asset of Acquiror or  MergerCo is bound or affected; or (iii) conflict
with, result in any breach  of,  constitute a default (or an event that,
with notice or lapse of time or both,  would become a default) under, or
require any consent of any Person pursuant  to,  any material contract or
agreement to which Acquiror or MergerCo is a party,  except, in the case of
clause (ii) or (iii), for any such conflicts, violations,  breaches, defaults
or other occurrences that would not, individually or in  the  aggregate,
reasonably be expected to have a material adverse effect on the ability  of
Acquiror or MergerCo to perform its obligations under this Agreement or  to 
consummate the transactions contemplated hereby.  

 

(b) Neither  Acquiror nor MergerCo is required to file, seek or obtain any
notice,  authorization, approval, order, permit or consent of or with any
Governmental  Authority in connection with the execution, delivery and
performance by Acquiror  and MergerCo of this Agreement or the consummation
of the transactions  contemplated hereby, except for (i) any filings required
to be made under  the  HSR Act, (ii) the filing of the Certificate of Merger
with the Secretary  of  State of the State of Delaware and (iii) such
filings as may be required  by any  applicable federal or state securities
or "blue sky" laws. To the Knowledge  of  Acquiror, there are no facts or
circumstances relating to Acquiror or any  of its  Affiliates that would
reasonably be expected to prevent or materially delay  the  consummation of
the transactions contemplated hereby. " _Knowledge  of Acquiror_ "  means 
the actual (but not constructive or imputed) knowledge of the persons listed 
on  _Schedule  1.1(a)_   as of  the date of this Agreement without any
implication of verification or  investigation concerning such knowledge.

 

 

Section  5.4 _No  Prior Activities_.  Except  for obligations incurred in
connection with its organization and the  transactions contemplated hereby,
MergerCo has neither incurred any obligation  or liability nor engaged in any
business or activity of any type or kind  whatsoever or entered into any
agreement or arrangement with any  Person.

 


 

 

 

 

 

 

 

28  

 

 

 

 

 

 

 

Section  5.5 _No  Outside Reliance_.  Neither  Acquiror nor MergerCo has
relied or is relying on any statement, representation  or warranty concerning
the Company, any of its Subsidiaries or any of its  Representatives other
than those expressly made in this Agreement.

 

 

Section  5.6 _Financing;  Solvency_.

 

 

(a) (i) Acquiror  has received and accepted and agreed to a commitment letter
dated October 19,  2006 (the " _Commitment  Letter_ ")  from  Credit
Suisse, Credit Suisse Securities (USA) LLC, CIBC World Markets Corp.  and 
CIBC Inc. (collectively, the " _Lenders_ ")  relating to the commitment of
the Lenders to provide senior debt financing  (the  " _Bank  Financing_
")  and  high yield bridge financing (the " _Bridge  Financing_ ")  in
an  aggregate amount of $755,000,000 to consummate the transactions
contemplated  hereby (such debt financing, the " _Financing_ "). 

 

 

(ii) A  complete and correct copy of the Commitment Letter has been provided
to the  Company.

 

 

(iii) Subject  to its terms and conditions, the Financing, when funded in
accordance with  the  Commitment Letter, shall provide Acquiror with
acquisition financing at the  Closing sufficient to consummate the
transactions contemplated by this Agreement  on the terms contemplated by
this Agreement and to pay related fees and  expenses.

 

 

(iv) The  Commitment Letter is valid, binding and in full force and effect
and no event  has occurred which, with or without notice, lapse of time or
both, would  reasonably be expected to constitute a default or breach or an
incurable failure  to satisfy  a  condition precedent on the part of
Acquiror under the terms and conditions  of  the Commitment Letter. Acquiror
has no reason to believe that it will be unable  to satisfy on a timely basis
any term or condition of closing to be satisfied  by  it contained in the
Commitment Letter. Acquiror has paid in full any and all  commitment fees or
other fees required to be paid pursuant to the terms of  the  Commitment
Letter on or before the date of this Agreement. There are no  conditions
precedent or other contingencies related to the funding of the full  amount
of the Financing, other than as set forth in the Commitment  Letter.

 

 

  (b) Each  of  Acquiror and MergerCo acknowledge and agree that its
obligations to consummate  the transactions contemplated hereby are not
contingent upon its ability to  obtain any third-party financing.

 

 

(c) As  of the  Closing, Acquiror shall have taken all measures necessary to
ensure that  MergerCo will have sufficient cash on hand to pay the Purchase
Price. In  addition, as of the Closing, Acquiror shall have taken all
measures necessary,  including, without limitation, the contribution of
capital to MergerCo, to  ensure that, after giving effect to the transactions
contemplated by this  Agreement, including the payment of the Purchase Price
and the satisfaction  of  all liabilities of the Surviving Corporation, (i)
the Surviving Corporation  (or its successors and assigns) will be Solvent
and (ii) the Present  Fair Saleable Value of the assets of


 

 

 

 

 

 

 

29  

 

 

 

 

 

 

the  Surviving Corporation will exceed its debt, plus its total "capital", as
such  term is determined in accordance with Section 154 of the DGCL.

 

 

(d) For  purposes of this Agreement, " _Solvent_ "  when  used with respect
to the Surviving Corporation (or its successors and assigns),  means that, as
of any date of determination (i) the amount of the Present  Fair Saleable
Value of its assets will, as of such date, exceed all of its  liabilities,
contingent or otherwise, as of such date, (ii) the Surviving  Corporation
will not have, as of such date, an unreasonably small amount of  capital for
the business in which it is engaged or will be engaged and  (iii) the
Surviving Corporation (or its successors and assigns) will  be able to pay
its debts as they become absolute and mature, taking into account  the timing
of and amounts of cash to be received by it and the timing of and  amounts of
cash to be payable on or in respect of its indebtedness, in each  case 
after giving effect to the transactions contemplated by this Agreement. The 
term  " _Solvency_ "  shall  have its correlative meaning.

 

 

Section  5.7 _Brokers_.  Except  for MTS Health Partners, L.P., the fees of
which will be paid by Acquiror,  neither Acquiror nor any party acting on its
behalf has paid or become obligated  to pay any fee or commission to any
broker, finder or intermediary for or on  account of the transactions
contemplated by this Agreement.

 

 

**ARTICLE  VI**

 

**COVENANTS**

 

 

Section  6.1 _Conduct  of Business Prior to the Closing_.  Except  as set
forth on _Schedule  6.1 of the Disclosure Schedules_ ,  or  otherwise
consented to in writing by Acquiror (which consent shall not be  unreasonably
withheld or delayed), for the period commencing on the date hereof  and
ending on the Closing Date, the Company shall conduct its business, and 
shall  cause its Subsidiaries to conduct their businesses, in the ordinary
course  consistent with past practice. Without limiting the generality of the
foregoing,  for the period commencing on the date hereof and ending on the
Closing Date,  except as expressly contemplated by this Agreement or as set
forth on  _Schedule  6.1 of the Disclosure Schedules_ ,  or  otherwise
consented to in writing by Acquiror (which consent shall not be  unreasonably
withheld or delayed), neither the Company nor any of its  Subsidiaries
will: 

 

(a) amend  its  certificate of incorporation or bylaws or equivalent
organizational  documents;

 

 

(b) issue,  transfer or sell any shares of capital stock of the Company or
any of its  Subsidiaries, or any options, warrants, convertible securities or
other rights  of any kind to acquire any such shares, except in connection
with the exercise  or vesting of the Company Stock Options;

 

 

(c) declare,  set aside, make or pay any dividends or other distributions
(whether in cash,  stock, property or otherwise) with respect to any of its
capital stock, except  for dividends, distributions or other payments made by
any direct or indirect  wholly-owned Subsidiary of the Company to any other
Subsidiary or the Company  and except for dividends of additional shares of
Preferred Stock with respect  to  the Preferred Stock as required pursuant
to the terms of the Certificate  of  Designations;

 


 

 

 

 

 

 

 

30  

 

 

 

 

 

 

 

(d) reclassify,  combine, split, subdivide or redeem, or purchase or
otherwise acquire, directly  or indirectly, any of its capital stock or any
options, warrants, convertible  securities or other rights of any kind to
acquire such capital stock or make  any  other change with respect to its
capital structure;

 

 

(e) acquire,  or dispose of, stock or other securities or assets of any
Person, except in  connection with acquisitions or dispositions of inventory
or equipment in the  ordinary course of business consistent with past
practice;

 

 

(f) adopt  a  plan of complete or partial liquidation, dissolution, merger,
consolidation  or  recapitalization of the Company or any of its
Subsidiaries;

 

 

(g) take  any  actions that would result in the Company and its Subsidiaries
having  Indebtedness (including, for clarity, letters of credit) in excess
of  $350,000,000 plus any Indebtedness required to purchase or lease
properties  under the Restated Master Lease dated as of August 1, 2002, as
extended on  May  30, 2006, between Harborside Massachusetts Limited
Partnership and Nationwide  Health Properties, Inc.;

 

 

(h) except  as  contemplated by the Company\'s capital expenditures budgets
for 2006 and 2007  included on _Schedule  6.1 of the Disclosure Schedules_
,  authorize, or make any payment or commitment with respect to, any single
capital  expenditure that is in excess of $250,000 or capital expenditures
that are,  in  the aggregate, in excess of $1,000,000 for the Company and
its Subsidiaries  taken as a whole;

 

 

(i) amend,  waive, modify or consent to the termination of any Material
Contract, or amend,  waive, modify or consent to the termination of the
Company\'s or any of its  Subsidiaries\' rights thereunder, or enter into any
contract, agreement or  arrangement that would be a Material Contract if
entered into prior to the  date  hereof, other than any such contracts,
agreements or arrangements entered into  in the ordinary course of business
consistent with past practice (including  contracts, agreements or
arrangements with customers, vendors, employees or  clients);

 

 

(j) enter  into any Material Contract with (i) any Affiliate of the Company,
(ii) any  director, officer or employee of the Company or (iii) any of its
Subsidiaries  or  any other Person not at arm\'s length to the Company;

 

 

(k) grant  or  announce any increase in the salaries, bonuses or other
benefits payable by  the  Company or any of its Subsidiaries to any of their
employees, other than as  required by Law, pursuant to existing commitments
on the date hereof under  any  plans, programs or agreements of the Company
or other normal merit increases  to  employees other than officers in the
ordinary course of business consistent  with  the past practices of the
Company or such Subsidiary;

 

 

(l) adopt,  amend in any material respect or terminate any Employee Plan or
enter into  any  new Employee Plan;

 

 

(m) create  any Encumbrance upon any of its properties or assets other than
Permitted  Encumbrances;

 

 

 

 

 

 

 

31  

 

 

 

 

 

 

 

(n) make  any  change in any method of accounting or accounting practice or
policy, except  as  required by applicable Law or GAAP;

 

 

(o) make  any  material Tax election, settle or compromise any United States
federal, state,  local or non-United States income tax liability or file any
Return other than  on  a basis consistent with past practice;

 

 

(p) commence  or settle any material Action; or

 

 

(q) commit,  authorize or agree to do any of the foregoing.

 

 

Section  6.2 _Covenants  Regarding Information_.

 

 

(a) From  the  date hereof until the Closing Date, upon reasonable notice,
the Company and  its  Subsidiaries shall afford Acquiror and its
Representatives reasonable access  to  the Representatives, properties,
offices, plants and other facilities, books  and  records of the Company and
its Subsidiaries, and shall furnish Acquiror with  such financial, operating
and other data and information as Acquiror may  reasonably request;
_provided_ ,  _however_ ,  that  any such access or furnishing of
information shall be conducted at Acquiror\'s  expense, during normal
business hours, under the supervision of the Company\'s  personnel and in
such a manner as not unreasonably to interfere with the normal  operations of
the Company and its Subsidiaries. Notwithstanding anything to  the  contrary
in this Agreement, neither the Company nor any of its Subsidiaries  shall be
required to disclose any information to Acquiror or its Representatives  if
such  disclosure would, in the Company\'s sole discretion, (i) jeopardize
any  attorney-client or other legal privilege or (ii) contravene any
applicable  Laws,  fiduciary duty or binding agreement entered into prior to
the date  hereof. 

 

(b) In  order  to facilitate the resolution of any claims made against or
incurred by the  Stockholders (as they relate to the Company and its
Subsidiaries), for a period  of 7 years after the Closing or, if shorter, the
applicable period specified  in  the Company\'s document retention policy
from time to time, the Company shall  (i)  retain the books and records
relating to the Company and its Subsidiaries  relating to periods prior to
the Closing and (ii) afford the Representatives  of  the Stockholder
Representative reasonable access (including the right to  make,  at the
applicable Stockholder\'s expense, photocopies), during normal business 
hours, to such books and records; _provided_ ,  _however_ ,  that  the
Company shall notify the Stockholder Representative in writing at least  30 
days in advance of destroying any such books and records prior to the
seventh  anniversary of the Closing Date in order to provide the
Stockholder  Representative and its Representatives the opportunity to copy
such books  and  records in accordance with this _Section  6.2(b)_.

 

 

Section  6.3 _Stockholder  Approval_.  The  Company shall use its
commercially reasonable efforts to deliver to Acquiror,  promptly following
the execution and delivery of this Agreement and in  accordance with the
DGCL, the Certificate of Incorporation, the Certificate  of  Designations
and the Bylaws, (i) a written consent of the Stockholders holding  at least
80% of the outstanding shares of Common Stock (measured by both  voting 
rights and including 100% of the outstanding shares of Class D Common Stock) 
approving the adoption of this 
 

 

 

 

 

 

 

32  

 

 

 

 

 

 

 

 

Agreement  and the transactions contemplated hereby, including the COD
Amendment; (ii)  a  written consent of the holders of 100% of the
outstanding shares of Preferred  Stock approving the adoption of this
Agreement and the transactions contemplated  hereby, including the COD
Amendment, and a waiver by the holders of 100% of  the  outstanding shares
of Preferred Stock of appraisal rights under Section 262  of  the DGCL; and
(iii) a written waiver of appraisal rights under Section 262  of  the DGCL
by the holders of 100% of the outstanding shares of Class B Common  Stock.
Promptly following the execution and delivery of this Agreement and  the 
delivery of the consents described in the prior sentence, the Company shall 
(x)  file the COD Amendment with the Secretary of State of Delaware in
accordance  with the DGCL and (y) comply with the requirements of Sections
228 and 262  of  the DGCL.

 

 

Section  6.4 _Notification  of Certain Matters_.  Each  party hereto shall
give written notice to the other parties hereto promptly  upon  becoming
aware of (i) any occurrence, or failure to occur, of any event, which 
occurrence or failure to occur has caused or is reasonably likely to cause 
any  of its representations or warranties in this Agreement to be untrue or 
inaccurate in any material respect as of the Closing Date and (ii) any
material  failure by it to comply with or satisfy any covenant, condition or
agreement  to  be complied with or satisfied by it hereunder; _provided_ , 
that  the delivery of any notice pursuant to this _Section  6.4_   shall
in  no event (a) limit or otherwise affect the remedies available hereunder
to  the  other parties hereto upon receiving such notice or (b) survive or
have any  effect following the Closing.

 

 

Section  6.5 _No  Solicitation_.  If this  Agreement is terminated prior
to the Effective Time, neither Acquiror nor its  Affiliates will, prior to
December 13, 2007, directly or indirectly,  without the prior written consent
of the Company, solicit (other than a  solicitation by general advertisement)
any person who is an employee of the  Company, at the date hereof or at any
time hereafter that precedes such  termination, to terminate his or her
employment with the Company.  Notwithstanding the foregoing, neither Acquiror
nor its Affiliates shall be  precluded from hiring an employee of the Company
who has been terminated by  the  Company prior to commencement of employment
discussions between such party  and  such employee, _provided_   that 
such hiring is consistent with such employee\'s contractual obligations to
the  Company. Further, Acquiror shall be permitted to utilize general
newspaper  advertising and recruiters so long as the Company\'s employees are
not identified  to the recruiters and are not otherwise specifically targeted
by such  advertising or recruiters. Acquiror agrees that any remedy at law
for any breach  by Acquiror of this _Section  6.5_   would be  inadequate,
and that the Company would be entitled to injunctive relief in  such  a
case. If it is ever held that this restriction on Acquiror is too onerous 
and  is not necessary for the protection of the Company, Acquiror agrees that
any  court of competent jurisdiction may impose such lesser restrictions that
such  court may consider to be necessary or appropriate properly to protect
the  Company.

 

 

Section  6.6 _Takeover  Statutes_.  If any  state takeover statute or
similar Law shall be or become applicable to the  transactions contemplated
by this Agreement, each of the Company, Acquiror  and  MergerCo and their
respective Boards of Directors shall grant such approvals  and  shall take
such actions as are reasonably necessary so that the transactions 
contemplated hereby may be consummated as promptly as practicable on the
terms  contemplated hereby and otherwise act to eliminate or minimize the
effects  of  such statute or Law on the transactions contemplated hereby.

 

 

 

 

 

 

 

33  

 

 

 

 

 

 

 

Section  6.7 _Employee  Benefits_.

 

 

(a) Acquiror  shall provide, or cause to be provided, to the employees of the
Company and  its  Subsidiaries as of the Effective Time (the " _Affected 
Employees_ "),  for a  period of 1 year following the Effective Time,
compensation and employee  benefits that in the aggregate are comparable to
either (i) those currently  provided by the Company and its Subsidiaries to
their employees and as disclosed  to the Acquiror prior to the date hereof
(but without regard to equity-based  compensation, non-qualified deferred
compensation and change of control benefits  provided by the Company and its
Subsidiaries) or (ii) subject to the terms  of  any applicable collective
bargaining agreement, those provided to similarly  situated employees of
Acquiror and its Affiliates, **** and  Acquiror shall cause to be provided to
any Affected Employee who is  involuntarily terminated (other than for cause
or poor performance) during  such  1-year period following the Effective
Time severance benefits comparable in  the  aggregate to those currently
provided by the Company and its Subsidiaries to  similarly situated
employees.

 

 

(b) Acquiror  shall, or shall cause the Surviving Corporation to, honor all
unused vacation,  holiday, sickness and personal days accrued as of the
Closing Date by the  employees of the Company and its Subsidiaries under the
policies and practices  of the Company and its Subsidiaries. In the event of
any change within the  1-year period following the Closing Date in the
welfare benefits provided to  any  employee of the Company or any of its
Subsidiaries under any plan, Acquiror  shall, or shall cause the Surviving
Corporation to, (i) waive all limitations  as  to preexisting conditions,
exclusions and waiting periods with respect to participation  and coverage
requirements applicable to the Affected Employees and their covered 
dependents under such plan (except to the extent that such conditions, 
exclusions or waiting periods would apply under the Company\'s or such 
Subsidiary\'s then existing plans absent any change in such welfare coverage 
plan) and (ii) provide each Affected Employee and his or her covered
dependents  with credit for any co-payments and deductibles paid prior to any
such change  in  coverage in satisfying any applicable deductible or out-of-
pocket requirements  under such new or changed plan. Acquiror shall, or shall
cause the Surviving  Corporation to, provide each Affected Employee with
credit for all service  with  the Company and its Affiliates under each
employee benefit plan, policy, program  or arrangement in which such Affected
Employee is eligible to participate,  except to the extent that such credit
would result in a duplication of benefits  with respect to the same period of
services. 

 

(c) Nothing  in this Agreement shall be deemed to constitute an amendment to
any employee  benefit plan of the Company, Acquiror or any of their
Affiliates.

 

 

Section  6.8 _Confidentiality_.  Any  information provided to Acquiror or
its Representatives pursuant to this  Agreement shall be held by Acquiror and
its Representatives in accordance  with,  and shall be subject to the terms
of, the Confidentiality Agreement dated  June  13, 2006 by and between
Acquiror and the Company (the " _Confidentiality  Agreement_ "). 

 

 

Section  6.9 _Consents  and Filings; Further Assurances_.

 

 

(a) Each  of  the parties hereto shall use his, her or its commercially
reasonable efforts  to  take, or cause to be taken, or do, or cause to be
done, all things necessary,  proper or advisable under applicable Law to
obtain all regulatory approvals  and  to cause the transactions

 


 

 

 

 

 

 

 

34  

 

 

 

 

 

 

contemplated  hereby to be completed in accordance with the terms hereof as
promptly as  practicable and shall cooperate fully with each other party and
their respective  Representatives in connection with any steps required to be
taken as a part  of  their respective obligations under this Agreement,
including without  limitation:

 

 

(i) Promptly  upon execution and delivery of this Agreement, each of
Acquiror, MergerCo and  the Company shall prepare and file as promptly as
possible, or cause to be  prepared and filed, with the appropriate
Governmental Authority, notification  with respect to the transactions
contemplated by this Agreement pursuant to  the  HSR Act, supply all
information required by such Governmental Authority in  connection with the
HSR Act notification and cooperate with each other in  responding to any such
request. Each of the parties shall cooperate with each  other in promptly
filing any other necessary applications, reports or other  documents with any
Governmental Authority having jurisdiction with respect  to  this Agreement
and the transactions contemplated hereby, and in seeking  necessary
consultation with and prompt favorable action by such Governmental 
Authority.

 

 

(ii) Notwithstanding  anything herein to the contrary, each of Acquiror and
MergerCo agrees to use  its  commercially reasonable efforts and to take any
and all steps necessary to  avoid  or eliminate each and every impediment
under any antitrust, competition or  trade  regulation Law that may be
asserted by any United States or non-United States  governmental antitrust
authority or any other party so as to enable the parties  hereto to
expeditiously  consummate the transactions contemplated hereby no later than
the Termination  Date. In addition, Acquiror shall use its commercially
reasonable efforts to  defend through litigation on the merits any claim
asserted in court by any  party  in order to avoid entry of, or to have
vacated or terminated, any decree, order  or judgment (whether temporary,
preliminary or permanent) that would prevent  the  Closing from occurring by
the Termination Date. In the event any claim, action,  suit, investigation,
or other proceeding by any Governmental Authority or other  Person is
commenced which questions the validity or legality of the transactions 
contemplated hereby or seeks damages in connection therewith, the parties
agree  to cooperate and use commercially reasonable efforts to defend against
such  claim, action, suit, investigation, or other proceeding and, if an
injunction  or  other order is issued in any such action, suit or other
proceeding, to use  commercially reasonable efforts to have such injunction
or other order lifted,  and to cooperate reasonably regarding any other
impediment to the consummation  of the transactions contemplated hereby.  

 

(b) The  Company shall use its commercially reasonable efforts to obtain all
consents,  waivers and approvals under any Material Contract or lease with
respect to  any  Leased Real Property listed or required to be listed under
_Schedule  4.3(a)(iv) of the Disclosure Schedules_.

 

 

Section  6.10 _Public  Announcements_.  Prior  to the Closing Date, no
party hereto shall, without the prior approval of  the  other parties hereto
(which shall not be unreasonably withheld), issue any  press  release or
make any other public announcement concerning the transactions  contemplated
by this Agreement, except as and to the extent that any such  disclosing
party shall be so obligated by Law or the requirements of any  applicable
stock exchange, in which case the other parties hereto shall be  advised, and
the disclosing party shall use its

 


 

 

 

 

 

 

 

35  

 

 

 

 

 

 

reasonable  efforts to give the other parties advance opportunity to review
and comment  on  such release or announcement.

 

 

Section  6.11 _Directors\'  and Officers\' Indemnification._

 

 

(a) Acquiror  shall, and shall cause the Surviving Corporation and its
Subsidiaries to,  indemnify, defend and hold harmless each person who is now,
or has been at  any  time prior to the date hereof or who becomes prior to
the Closing Date, an  officer or director of the Company or any of its
Subsidiaries (the " _D andO  Indemnified Parties_")  against any and all
losses, damages, liabilities, deficiencies, claims,  interests, awards,
judgments, penalties, costs and expenses (including  reasonable attorneys\'
fees, costs and other out-of-pocket expenses incurred  in  investigating,
preparing or defending the foregoing) arising out of or relating  to any
threatened or actual Action based in whole or in part on or arising  out  of
or relating in whole or in part to the fact that such person is or was a 
director or officer of the Company or any of its Subsidiaries, whether 
pertaining to any matter existing or occurring at or prior to the Closing
Date  and whether asserted or claimed prior to, at or after, the Closing Date
(the  " _D andO  Indemnified Liabilities_"),  including all DandO Indemnified
Liabilities based in whole or in part on, or  arising in whole or in part out
of, or relating to this Agreement or the  transactions contemplated hereby,
in each case to the full extent a corporation  is permitted under applicable
Law to indemnify its own directors or officers  (and Acquiror shall, or shall
cause the Surviving Corporation and its  Subsidiaries to, pay expenses in
advance of the final disposition of any such  Action to each DandO
Indemnified  Party). Without limiting the foregoing, in the event any such
Action is brought  against any DandO Indemnified Party (whether arising before
or after the  Closing Date), (i) the DandO Indemnified Party may retain
counsel  satisfactory to it and reasonably satisfactory to Acquiror, and
Acquiror shall,  or shall cause the Surviving Corporation and its
Subsidiaries to, pay all fees  and expenses of such counsel for the DandO
Indemnified Party promptly as  statements therefor are received and (ii)
Acquiror, the Surviving  Corporation, its Subsidiaries and each DandO
Indemnified Party will use all  reasonable efforts to assist in the vigorous
defense of any such matter;  _provided_ ,  that  none of the Surviving
Corporation, any of its Subsidiaries or Acquiror shall  be  liable for any
settlement effected without its prior written consent. Any  DandO Indemnified
Party wishing to claim indemnification under this  _Section  6.11_  
shall  notify Acquiror upon learning of any such Action or investigation (but
the  failure so to notify shall not relieve a party from any liability which
it  may  have under this _Section  6.11,_   except  to the extent such
failure prejudices such party). The parties hereto agree  that  all rights
to indemnification hereunder, including provisions relating to  advances of
expenses incurred in defense of any such Action existing in favor  of  the
DandO Indemnified Parties with respect to matters occurring through the 
Closing Date, shall continue in full force and effect for a period of not
less  than 6 years from the Closing Date; _provided_ ,  _however_ , __
that  all  rights to indemnification in respect of any DandO Indemnified
Liabilities  asserted or made within such period shall continue until the
disposition of  such  DandO Indemnified Liabilities. 

 

(b) For  a  period of 6 years from the Closing Date, Acquiror shall cause
the Surviving  Corporation and its Subsidiaries to maintain, if available,
officers\' and  directors\' liability insurance and fiduciary insurance
covering the persons  who  are presently covered by their existing
officers\' and directors\' or fiduciary  liability insurance policies on
terms no less advantageous to such indemnified  parties than such existing
insurance; _provided_ ,  _however_ ,  that  Acquiror shall not be required
to pay more than 200% of the premium paid  by the  Company for

 


 

 

 

 

 

 

 

36  

 

 

 

 

 


 

such  existing officers\' and directors\' or fiduciary liability insurance
policies  during the year immediately preceding the date hereof, which
premium is set  forth on _Schedule  6.11(b) of the Disclosure Schedules_.

 

 

(c) From  and  after the Closing, Acquiror agrees that it will cause the
Surviving Corporation  to continue to indemnify and hold harmless each
present and former director  and  officer of the Company against any costs
or expenses (including reasonable  attorneys\' fees), judgments, fines,
losses, claims, damages or liabilities  incurred in connection with any
Action or investigation, whether civil,  criminal, administrative or
investigative, arising out of or pertaining to  matters existing or occurring
on or prior to the Closing, whether asserted  or  claimed prior to, on or
after the Closing, to the fullest extent that the  Company would have been
permitted under the DGCL and its certificate of  incorporation, bylaws or
other organizational documents in effect on the date  hereof to indemnify
such person (including the advancing of expenses as incurred  to the fullest
extent permitted under applicable Law); _provided_ ,  _however_ ,  that 
the person to whom such expenses are advanced must provide an undertaking to 
the  Company (as appropriate) to repay such advances if it is ultimately
determined  by a court of competent jurisdiction (which determination shall
have become  final) that such person is not entitled to indemnification.

 

 

Section  6.12 _Financing_.

 

 

 

  (a) Acquiror  shall use commercially reasonable efforts to arrange and
consummate on or  before  the Outside Funding Date the Bank Financing and,
unless a high yield bond  offering in an amount at least equal to the amount
of the Bridge Financing  contemplated by the Commitment Letter (the "Bond
Financing") is consummated  on  or prior to the Outside Funding Date
(including by funding into escrow),  the  Bridge Financing, in each case
consistent with the provisions set forth in  this  _Section  6.12_   and
on  the terms and conditions described in the Commitment Letter, including
using  commercially reasonable efforts to (i) negotiate definitive agreements
with  respect to the Financing on the terms and conditions contained in the
Commitment  Letter on a timely basis, (ii) satisfy on a timely basis all
conditions  applicable to Acquiror in such definitive agreements that are
within the  control  of Acquiror and (iii) cooperate with the Company in
ensuring that the Offering  Document (as defined in the Commitment Letter) is
made available to the  Investment Bank (as defined in the Commitment Letter)
at least 21 days prior  to  the Outside Funding Date (or the earlier date
specified in Section 6.12(d),  as  applicable) and the Investment Bank is
afforded a marketing period of at  least  21 consecutive days prior to the
Outside Funding Date, all as contemplated  by  paragraph 9 of Exhibit D to
the Commitment Letter. Acquiror shall use its  commercially reasonable
efforts to comply with its obligations, and enforce  its  rights, under the
Commitment Letter. In the event that any portion of the  Financing becomes
unavailable on the terms and conditions contemplated in  the  Commitment
Letter, Acquiror shall use its commercially reasonable efforts  to  obtain
any such portion from alternative sources as promptly as  practicable.

 

 

(b)   Notwithstanding anything herein to the contrary, in the event that by
the  last  day of the Marketing Period (or by May 9, 2007, if the (1) CP
Satisfaction  Date  occurs after April 15, 2007 and on or before May 9, 2007
and (2) the 2006  Year-End Required Financial Statements are made available
to Aquiror on or  before March 31, 2007 (the conditions in (1) and (2) being,
collectively,  the  " _Pre-Funding  Condition_ "))  all  or any portion
of any Bond Financing has not been consummated, then Acquiror  shall cause
the proceeds of the Bridge Financing to be

 


 

 

 

 

 

 

 

37  

 

 

 

 

 


 

funded  no  later than (i) on the last day of the Marketing Period (or on
May 9, 2007,  if  the Pre-Funding Condition is satisfied) or (ii) 25 days
following the CP  Satisfaction Date, whichever is later (the period from the
CP Satisfaction  Date  to a date selected by the Acquiror that is no later
than 25 days thereafter  being the " _Bank  Syndication Period_ ")  . The 
later of (1) the last day of the Marketing Period (or if the Pre-Funding 
Condition is satisfied, May 9, 2007) and (2) the last day of the Bank 
Syndication Period is referred to herein as the " _Outside  Funding Date_
,"  provided that if the Commitment Letter expires or terminates prior to
such  date,  the Outside Funding Date shall be the last day on which the
Commitment Letter  remains in effect. The period from the CP Satisfaction
Date to the Outside  Funding Date is referred to herein as the " _Financing 
Period_."  " _Marketing  Period_ "  means  the first period of 25
consecutive days, ending not later than the Termination  Date, commencing on
the later to occur of (i) the satisfaction or waiver of  all  the conditions
set forth in Article VII (other than those conditions that,  by  their
terms, may only be satisfied at the Closing) (the date on which such 
conditions are first satisfied or waived being the _"CP  Satisfaction Date_
")  and  (ii) the receipt by Acquiror of the Required Financial Information
for such  Marketing Period; _provided_   that the  "Marketing Period" shall
not be deemed to have commenced or occurred if (A)  prior to the completion
of any such consecutive 25 day period, the Company\'s  independent
accountants shall have withdrawn their audit opinion with respect  to  any
financial statements contained in the Required Financial Information or 
(B)  such Required Financial Information shall not have remained sufficient
under  Rule 3-05 of Regulation S-X of the  rules  and regulations
promulgated by the Securities and Exchange Commission (except  that this
clause (B) shall not apply after May 9, 2007 if the Pre-Funding  Condition is
satisfied). 

 

(c) The  Company shall assist and cooperate with Acquiror, __ and  shall 
use its commercially reasonable efforts to cause its Representatives to
assist  and cooperate with Acquiror, in connection with Acquiror\'s efforts
to obtain  the  proceeds of the Financing. Without limiting the generality
of the foregoing,  the  Company shall use its commercially reasonable
efforts to direct (to the extent  it reasonably can) its Representatives to
use their commercially reasonable  efforts to, at the request of Acquiror,
(i) provide, in accordance with the  terms of _Section  6.2_ ,  reasonably
required information relating to the Company to the financial  institution or
institutions providing the Financing, (ii) participate  in a reasonable
number of meetings, presentations, road shows, due diligence  sessions and
sessions with rating agencies, (iii) assist with the  preparation of
materials for rating agency presentations, offering documents,  private
placement memoranda and similar documents required in connection  with  the
Financing, (iv) obtain accountants\' consents, comfort letters, legal 
opinions, surveys and title insurance as reasonably requested by Acquiror 
and  (v)  execute and deliver customary certificates or other documents and
instruments  relating to guarantees, the pledge of collateral and other
matters ancillary  to  the Financing as may be reasonably requested by
Acquiror __ in  connection with the Financing; _provided_ ,  _however_ , 
that no  obligation of the Company or any of its Subsidiaries under any such
certificate,  document or instrument shall be effective until the Closing and
none of the  Company or any of its Subsidiaries shall be required to pay any
commitment  or  other fee or incur any other liability or expense in
connection with the  Financing.

 

 

(d) Notwithstanding  anything herein to the contrary, (i) if the CP
Satisfaction Date shall not  have  occurred on March 31, 2007 and the 2006
Year-End Required Financial Information  is delivered to Acquiror on or
before March 31, 2007, or (ii) if the CP  Satisfaction Date shall not have
occurred on May 31, 2007 and the March 2007  Required Financial Information
is delivered to Acquiror on or before May  31,  2007, in each case Acquiror
shall, in

 


 

 

 

 

 

 

 

38  

 

 

 

 

 

 

accordance  with the requirements of _Section  6.12(a)_ ,  deliver  to the
Investment Bank an Offering Document, no later than April 9, 2007 or  June 
1, 2007, as applicable.

 

 

Section  6.13 _Financial  Statements_.

 

 

(a) The  Company shall furnish Acquiror and its Financing sources not later
than December  31, 2006 with financial statements and financial data of the
type required  by  Regulation S-X and Regulation S-K under the Securities
Act of 1933, as  amended (the " _Securities  Act_ "),  and  of the type
and form customarily included in private placements under  Rule 144A of the
Securities Act to consummate the offerings of debt  securities contemplated
by the Financing, with respect to the 3 years ended  December 31, 2005 and
the 9-month periods ended September 30, 2006 and 2005  (the  " _September 
2006 Required Financial Information_ ").  Notwithstanding the previous
sentence, the Company shall use its commercially  reasonable efforts to
furnish Acquiror and its Financing sources with the  September 2006 Required
Financial Information as promptly as reasonably  practicable after December
1, 2006.

 

 

 

(b) The  Company shall furnish Acquiror and its Financing sources not later
than March  31, 2007 with financial statements and financial data of the type
required  by  Regulation S-X and Regulation S-K under the Securities Act,
and of the  type and form customarily included in private placements under
Rule 144A of  the Securities Act to consummate the offerings of debt
securities contemplated  by the Financing, with respect to the three years
ended December 31, 2006  (the  " _2006  Year-End Required Financial
Information_ ").  Notwithstanding the previous sentence, the Company shall
use its commercially  reasonable efforts to furnish Acquiror and its
Financing sources with the  2006  Year-End Required Financial Information as
promptly as reasonably practicable  after March 1, 2007.

 

 

(c) The  Company shall furnish Acquiror and its Financing sources not later
than May  31,  2007 with financial statements and financial data of the type
required by  Regulation S-X and Regulation S-K under the Securities Act, and
of the  type and form customarily included in private placements under Rule
144A of  the Securities Act to consummate the offerings of debt securities
contemplated  by the Financing, with respect to the 3-month periods ended
March 31, 2007  and  2006 (the " _March  2007 Required Financial
Information_ ").  Notwithstanding the previous sentence, the Company shall
use its commercially  reasonable efforts to furnish Acquiror and its
Financing sources with the  March  2007 Required Financial Information as
promptly as reasonably practicable  after  May 10, 2007.

 

 

(d) For  purposes of this Agreement, " _Required  Financial Information_ " 
shall  mean: (i) with respect to any Marketing Period ending on or prior to
February  6,  2007, the September 2006 Required Financial Information, (ii)
with respect  to  any Marketing Period ending after February 6, 2007, but on
or before May  9,  2007, the 2006 Year-End Required Financial Information,
and (iii) with respect  to any Marketing Period ending after May 9, 2007, the
March 2007 Required  Financial Information, it being understood that for
purposes of this sentence,  the end of the Marketing Period shall be 25 days
after the CP Satisfaction  Date,  provided that if the Required Financial
Information for such Marketing Period,  as so determined, shall not have been
delivered on or before 25 days prior  to  the date on which a different
clause of this sentence (i.e. clause (ii) rather  than clause (i), or clause
(iii), rather than clause (ii), as applicable)  would  determine the
Required Financial

 


 

 

 

 

 

 

 

39  

 

 

 

 

 


 

Information,  the Required Financial Information shall be determined on the
basis of that  different clause, except that if that different clause is
clause (ii) of this  sentence and the 2006 Year-End Required Financial
Information is not delivered  at least 25 days prior to May 9, 2007, the
Required Financial Information shall  in any event be the March 2007 Required
Financial Information. Notwithstanding  the foregoing, if the Pre-Funding
Condition is satisfied, the Required Financial  Information shall be the 2006
Year-End Required Financial  Information.

 

 

Section  6.14 _Parachute  Payments_.  With  respect to each employee of
the Company who is, or would reasonably be expected  to be as of the Closing
Date, a "disqualified individual" (as defined in  Section 280G(c) of the
Code), the Company shall (i) obtain all  necessary waivers from any such
employee of the portion of any payments or  economic benefit that would
otherwise constitute a "parachute payment" (as  defined in Section 280G(b)(2)
of the Code), which portion would be exempt  from the definition of
"parachute payment" by reason of the exemption provided  under Section
280G(b)(5)(A)(ii) of the Code if the shareholder approval  required by such
Section were obtained, and (ii) use its commercially  reasonable efforts to
so exempt  such payments (including, without limitation, obtaining any
necessary  shareholder consents) as soon as reasonably practicable following
the date  of  this Agreement. Within a reasonable period of time prior to
taking such  actions, the Company shall deliver to Acquiror for review and
comment a copy  of  any documents or agreements necessary to effect this
_Section 6.14_,  including but not limited to, any consent form, disclosure
statement or  waiver. 

 

Section  6.15 _Stockholder  Information_.  Prior  to the Closing, the
Company shall deliver to Acquiror duly executed certificates  representing
certain information regarding ownership changes by stockholders  of  the
Company substantially in the form provided by the Company to Acquiror 
prior  to the date hereof, but with required identifying information added to
such  forms and otherwise as are reasonably acceptable to Acquiror for
purposes  of  determining compliance with Section 382 of the Code.

 

 

Section  6.16 _Transaction  Expenses_.  On the  Closing Date, the Company
shall deliver to Acquiror payment letters addressed  to  the Company from
each of the Company\'s investment bankers, attorneys,  accountants, advisors,
consultants and all other third-party service providers  to whom payments
that constitute Company Transaction Expenses and exceed  $10,000  are
required to be made by the Company in connection with the transactions 
contemplated by this Agreement. The payment letters shall state that the 
amounts  set forth therein represent payment in full for all fees and
expenses payable  by  the Company in connection with the transactions
contemplated by this Agreement. 

 

 

Section  6.17 _Transaction  Expense Tax Benefit Payments_

 

 

(a) Acquiror  shall pay to each Stockholder, holder of Warrants and holder of
Company Stock  Options an amount equal to (i) (A) the Current Transaction
Expense Tax Benefit  _divided_   by (B)  the Fully Diluted Shares, _times_
  (ii) the  aggregate number of shares of Common Stock, Warrants, Company
Stock Options  and  shares of Common Stock issuable upon conversion on the
Closing Date of the  Preferred Stock outstanding on the Closing Date, in each
case, held by such  Person immediately prior to the Effective Time (the
applicable " _Stockholder  Benefit_ ")  within  10 days of the filing of
the federal income tax return of the Company for  the  taxable period of the
Company beginning on January 1, 2007 and ending on  the  Closing Date

 


 

 

 

 

 

 

 

40  

 

 

 

 

 

 

(the  " _Short  2007 Tax Year_ ").  The  Current Transaction Expense Tax
Benefit shall be considered paid and fully  satisfied by Acquiror when
Acquiror delivers by wire transfer of immediately  available funds (i) to the
Stockholder Representative, the aggregate Stockholder  Benefit payable to all
Wire Transfer Recipients (ii) to the Paying Agent, the  aggregate Stockholder
Benefit payable to all Stockholders and holders of  Warrants who are not Wire
Transfer Recipients and (iii) to the Company, the  aggregate Stockholder
Benefit payable to all holders of Company stock Options.  The Stockholder
Representative shall deliver, from the amount paid to it by  Acquiror, to
each Wire Transfer Recipient, such Wire Transfer Recipient\'s  applicable
Stockholder Benefit. The Paying Agent shall deliver, from the amount  paid to
it by Acquiror, to each Stockholder and holder of Warrants who is not  a 
Wire Transfer Recipient, such Person\'s applicable Stockholder Benefit. The 
Company shall deliver, from the amount paid to it by Acquiror, to each
holder  of  Company Stock Options, such Person\'s applicable Stockholder
Benefit net of  any  amount the Company is required to deduct and withhold
with respect to the making  of such payment under the Code, or any provision
of applicable Tax Law. The  " _Current  Transaction Expense Tax Benefit 
Amount_ _"_   shall equal the actual reduction, if any, in Taxes of the
Company for the Short  2007 Tax Year as a result of the current deduction for
such Tax year of the  (i)  the amount of any Employee Merger Payments, (ii)
any compensation attributable  to payment to the holders of Company Stock
Options and (iii) any unamortized  deferred financing fees on the books of
the Company as of the Closing Date  (collectively, the "Deductible 
Transaction Expenses"),  computing the reduction for the Short 2007 Tax Year
by comparing the Tax  liability of the Company without the deduction for the
Deductible Transaction  Expenses against the Tax liability of the Company
with the deduction for the  Deductible Transaction Expenses for Short 2007
Tax Year, in both cases after  taking into account all other expenses,
losses, net operating loss carryovers  and other Tax attributes of the
Company.  

 

(b) Acquiror  shall pay to each Stockholder, holder of Warrants and holder of
Company Stock  Options an amount equal to (i) (A) the Future Transaction
Expense Tax Benefit  divided  by (B)  the Fully Diluted Shares times  (ii)
the  aggregate number of shares of Common Stock, Warrants, Company Stock
Options  and  shares of Common Stock issuable upon conversion on the Closing
Date of the  Preferred Stock outstanding on the Closing Date, in each case,
held by such  Person immediately prior to the Effective Time (the applicable
"Future  Stockholder Benefit")  within  10 days of receipt of such Future
Transaction Expense Tax Benefit. The Future  Transaction Expense Tax Benefit
shall be considered paid and fully satisfied  by  Acquiror when Acquiror
delivers by wire transfer of immediately available  funds  (i) to the
Stockholder Representative, the aggregate Future Stockholder Benefit  payable
to all Wire Transfer Recipients (ii) to the Paying Agent, the aggregate 
Future Stockholder Benefit payable to all Stockholders and holders of
Warrants  who are not Wire Transfer Recipients and (iii) to the Company, the
aggregate  Future Stockholder Benefit payable to all holders of Company stock
Options.  The  Stockholder Representative shall deliver, from the amount
paid to it by  Acquiror, to each Wire Transfer Recipient, such Wire Transfer
Recipient\'s  applicable Future Stockholder Benefit. The Paying Agent shall
deliver, from  the  amount paid to it by Acquiror, to each Stockholder and
holder of Warrants  who is  not a Wire Transfer Recipient, such Person\'s
applicable Future Stockholder  Benefit. The Company shall deliver, from the
amount paid to it by Acquiror,  to  each holder of Company Stock Options,
such Person\'s applicable Future  Stockholder Benefit net of any amount the
Company is required to deduct and  withhold with respect to the making of
such payment under the Code, or any  provision of applicable Tax Law. The
"Future  Transaction Expense Tax Benefit"  shall  equal the actual
reduction, if any, in Taxes 

 

 

 

 

 

 

 

41  

 

 

 

 

 

 

 

of  the  Company, Acquiror, or any Affiliate of Acquiror for any taxable
period of the  Company that begins after the Closing Date, or of Acquiror, or
any Affiliate  of  Acquiror, that includes or begins after the Closing Date
as a result of the  deduction of the Deductible Transaction Expenses
(including, for purposes of  this clause (b), any unamortized deferred
financing fees on the books of the  Company as of the Closing Date that were
not currently deductible in the Short  2007 Tax Year and that are amortized
in a later period) or the carryforward  of  net operating losses
attributable to such Deductible Transaction Expenses that  were not taken
into account in the Short 2007 Tax Year, computing the reduction  by
comparing the Tax liability of the Company, Acquiror, or any Affiliate of 
Acquiror, as the case may be, without the deduction for such Deductible 
Transaction Expenses against the Tax liability of the Company, Acquiror, or 
any  Affiliate of Acquiror, as the case may be, with the deduction for such 
Deductible Transaction Expenses for such taxable period, in all cases after 
taking into account all other expenses, losses, net operating loss
carryovers  and other Tax attributes of the Company, Acquiror, or any
Affiliate of  Acquiror, as the case may be, other than the Deductible
Transaction Expenses,  and shall be deemed received as of any date for the
payment of estimated Taxes  or as of the date of any refund of Taxes with
respect to which there has been  such an actual reduction in Taxes.

 

 

(c) With  respect to any Current Transaction Expense Tax Benefit or Future
Transaction  Expense Tax Benefit, at the time any such benefit is paid to the
Stockholders  in  accordance with _Section  6.17(a)_   and  _(b)_  
above  (or at such time as the Company determines that no such benefit is
payable),  the  Company shall provide the Stockholder Representative with
(i) a statement  setting forth sufficiently detailed information so as to
allow the Stockholder  Representative to determine whether the amount and
timing of such benefit is  correct (or, if the Company has determined that no
such benefit is currently  payable, sufficiently detailed information
supporting that determination) and  (ii) such additional information as is
reasonably requested by the Stockholder  Representative in making its
determination.

 

 

Section  6.18 _Preferred  Stock Redemption_.  Promptly  after the date of
this agreement, but in any event not later than December  31,  2006, the
Company shall use commercially reasonable efforts to redeem all  outstanding
shares, if any, of its 13-1/2%  Redeemable Preferred Stock,  par  value
$0.01 per share, pursuant to Article 5 of the Certificate of Designations  of
such stock.

 

 

**ARTICLE  VII**

 

**CONDITIONS  TO CLOSING**

 

 

Section  7.1 _General  Conditions_.  The  respective obligations of each
party hereto to consummate the transactions  contemplated by this Agreement
shall be subject to the fulfillment, at or prior  to the Closing, of each of
the following conditions, any of which may, to the  extent permitted by
applicable Law, be waived in writing by any party in its  sole discretion (
_provided_   that  such waiver shall only be effective as to the obligations
of such  party):

 

 

(a) no  Governmental Authority shall have enacted, issued or promulgated any
Law  (whether temporary, preliminary or permanent) that is then in effect
that  prevents or prohibits the consummation of the transactions contemplated
by  this  Agreement;

 

 

 

 

 

 

 

42  

 

 

 

 

 

 

 

(b) any  waiting period (and any extension thereof) under the HSR Act
applicable to  the  transactions contemplated by this Agreement shall have
expired or shall have  been terminated. All other material consents of, or
registrations, declarations  or filings with, any Governmental Authority
legally required for the  consummation of the transactions contemplated by
this Agreement shall have  been  obtained or filed;

 

 

(c) Company  Stockholder Approval shall have been validly obtained under the
DGCL, the  Certificate of Incorporation, the Certificate of Designations and
the Bylaws;  and the COD Amendment shall have been filed with the Secretary
of State of  Delaware in accordance with Sections 242 and 103 of the DGCL;
and

 

 

(d) all  regulatory approvals required in connection with the change of
ultimate  ownership and control of the Facilities resulting from the
transactions  contemplated by this Agreement, the consequence of the failure
to obtain such  approvals would be to prevent the Company  or any of its
Subsidiaries from lawfully continuing to operate, own or control  the
Facilities, including, without limitation, the approvals set forth on 
_Schedule  7.1(d) of the Disclosure Schedules_   (to the  extent that the
approvals set forth on such schedule are also set forth on  _Schedule 
4.3(a) of the Disclosure Schedules)_ ,  shall  have been obtained and remain
in effect.

 

 

Section  7.2 _Conditions  to Obligations of_ _the  Company_.  The 
obligations of the Company to consummate the transactions contemplated by
this  Agreement shall be subject to the fulfillment, at or prior to the
Closing,  of  each of the following conditions, which may be waived in
writing by the Company  in its sole discretion:

 

 

The  representations and warranties of Acquiror and MergerCo contained in
this  Agreement shall be true and correct both when made and as of the
Closing Date,  or in the case of representations and warranties that are made
as of a specified  date, such representations and warranties shall be true
and correct as of such  specified date, except where the failure of all the
representations and  warranties of Acquiror and MergerCo to be so true and
correct (without giving  effect to any limitation or qualification as to
"materiality" (including the  word "material") or "material adverse effect"
set forth therein) would not,  individually or in the aggregate, be
reasonably expected to have a material  adverse effect on Acquiror\'s or
MergerCo\'s ability to consummate the  transactions contemplated hereby.
Acquiror and MergerCo shall have performed  all  obligations and agreements
in _Section  3.2_   and  complied in all material respects with all other
covenants required by this  Agreement, in each case, to be performed or
complied with by them prior to  or at  the Closing. The Company shall have
received from each of Acquiror and MergerCo  a certificate stating that the
statements set forth in the preceding sentences  are true and accurate,
signed by a duly authorized officer of each of Acquiror  and MergerCo.

 

 

Section  7.3 _Conditions  to Obligations of Acquiror and MergerCo_.  The 
obligations of Acquiror and MergerCo to consummate the transactions
contemplated  by this Agreement shall be subject to the fulfillment, at or
prior to the  Closing, of each of the following conditions, any of which may
be waived in  writing by Acquiror and MergerCo in their sole discretion:

 

 

 

 

 

 

 

43  

 

 

 

 

 

 

 

(a) The  representations and warranties of the Company contained in this
Agreement shall  be true and correct both when made and as of the Closing
Date, or in the case  of  representations and warranties that are made as of
a specified date, such  representations and warranties shall be true and
correct as of such specified  date, except where the failure of all the
representations and warranties of  the  Company to be so true and correct
(without giving effect to any limitation  or  qualification as to
"materiality" (including the word "material") or "Material  Adverse Effect"
set forth therein) would not, individually or in the aggregate,  reasonably
be expected to have a Material Adverse Effect. The Company shall  have 
performed all obligations and agreements and complied with all covenants 
required by this Agreement, in each case, to be performed or complied with 
by it  prior to or at the Closing in all material respects. Acquiror and
MergerCo  shall  have received from the Company a certificate stating that
the statements set  forth in the preceding sentences are true and correct,
signed by a duly  authorized officer thereof;  

 

 

(b) The  Company shall have delivered to Acquiror a duly executed certificate
in a form  reasonably acceptable to Acquiror for purposes of satisfying
Acquiror\'s  obligations under Treasury Regulation Section 1.1445-2(c)(3);

 

 

(c) All  agreements between the Company or its Subsidiaries, on the one hand,
and  Investcorp International Inc. or any of its Affiliates (other than
directors  of  the Company and its Subsidiaries), on the other hand, shall
have been terminated  and the Company and its Subsidiaries shall have no
remaining obligations  thereunder other than indemnification obligations
owing to former directors  and  officers of the Company or its Subsidiaries
who are directors, officers or  employees of Investcorp International Inc. or
its Affiliates;

 

 

(d) The  Company shall have obtained consents or waivers from the other
parties to each  of the contracts set forth on _Schedule  7.3(d)_   to
the  effect that the consummation of the Merger and other transactions
contemplated  by this Agreement will not conflict with, result in any breach
of, constitute  a  default (or an event that, with notice or lapse of time
or both, would become  a  default), result in the creation of any
Encumbrance under, result in the loss  of  any benefit under or the
acceleration of any rights under or require a consent  pursuant to any of
such contracts; and

 

 

(e) There  shall not have occurred any Material Adverse Effect or any event
or circumstance  that, individually or in the aggregate, would be reasonably
expected to cause  a  Material Adverse Effect.

 

 

**ARTICLE  VIII**

 

**TERMINATION**

 

 

Section  8.1 _Termination_.  This  Agreement may be terminated, and the
Merger contemplated hereby may be  abandoned, at any time prior to the
Closing:

 

 

(a) by  unanimous written consent of Acquiror, MergerCo and the Company;

 

 

(b) (i)  by  the Company, if either of Acquiror or MergerCo breaches or
fails to perform  in  any material respect any of its material
representations, warranties or  covenants contained in this Agreement and
such breach or failure to perform  (A)  would give rise to the failure of a
condition set forth in _Section 7.2_,  (B)  cannot be or has not been cured
within 30 days 

 

 

 

 

 

 

 

44  

 

 

 

 

 

 

following  delivery of written notice of such breach  or failure to perform
and (C) has not been waived by the Company or (ii) by  Acquiror, if the
Company breaches or fails to perform in any material respect  any of its
material representations, warranties or covenants contained in this 
Agreement and such breach or failure to perform (x) would give rise to the 
failure of a condition set forth in _Section 7.3_,  (y)  cannot be or has
not been cured within 30 days following delivery of written  notice of such
breach or failure to perform and (z) has not been waived by  Acquiror; 

 

(c) by  either  the Company or Acquiror if the Merger shall not have been
consummated by  June  30, 2007 (the " _Termination  Date_ ");  _provided_
,  that  the right to terminate this Agreement under this _Section 8.1(c)_ 
shall  not be available if the failure of the party so requesting termination
to  fulfill any obligation under this Agreement shall have been the cause
of  the  failure of the Merger to be consummated on or prior to such date; 
or

 

 

 

(d) by  either  the Company or Acquiror in the event that any Governmental
Authority shall  have  issued an order, decree or ruling or taken any other
action enjoining or  otherwise prohibiting the transactions contemplated by
this Agreement and such  order, decree, ruling or other action shall have
become final and nonappealable;  _provided_ ,  that  the party so
requesting termination shall have complied with _Section __6.9_.

 

 

The  party  terminating this Agreement pursuant to this _Section 8.1_ 
(other  than _Section 8.1(a)_)  shall  give prompt written notice of such
termination to the other  parties.

 

 

Section  8.2 _Effect  of Termination_.  In the  event of termination of
this Agreement as provided in _Section 8.1_,  this  Agreement shall
forthwith become void and there shall be no liability on the  part of any
party except (a) for the provisions of _Sections 4.18_  and  _5.7_  
relating  to broker\'s fees and finder\'s fees, _Section 6.8_  relating  to
confidentiality, _Section 6.10_  relating  to public announcements, _Section
9.2_  relating  to fees and expenses, _Section 9.5_  relating  to notices,
_Section 9.8_  relating  to third-party beneficiaries, _Section 9.9_ 
relating  to governing law, _Section 9.10_  relating  to submission to
jurisdiction and this _Section 8.2_  and  (b) that nothing herein shall
relieve any party from liability for any  breach of this Agreement or any
agreement made as of the date hereof or  subsequent thereto pursuant to this
Agreement (except as set forth below).  In  the event that on the
Termination Date (i) the condition to Closing set forth  in  _Section 
7.1(d)_   has not  been satisfied and (ii) the other conditions to
Acquiror\'s obligation to close  set forth in _Section  7.1_   and 
_Section  7.3_   have  been satisfied (other than such conditions as may,
by their terms, only be  satisfied at the Closing or on the Closing Date,
which such conditions shall  be  capable of being satisfied on the
Termination Date), then Acquiror shall pay  to  the Company a termination
fee of $8,735,000 (the " _Termination  Fee_ ")  which  shall be the sole
and exclusive remedy of the Company in the event that the  transactions
contemplated hereby are not consummated solely as a result of  the  failure
of the condition set forth in _Section  7.1(d)_   (provided that the
Termination Fee shall not be the sole and exclusive remedy  in  the event
that the failure to obtain the approvals contemplated in _Section  7.1(d)_  
is  caused by Acquiror\'s failure to discharge its obligations to use
commercially  reasonable efforts to such secure such approvals hereunder).

 

 

 

 

 

 

 

45  

 

 

 

 

 

 

 

**ARTICLE  IX**

 

**GENERAL  PROVISIONS**

 

 

Section  9.1 _Nonsurvival  of Representations, Warranties_ _  and 
Covenants_.  The  respective representations, warranties and covenants of
the parties contained  in  this Agreement and any certificate delivered
pursuant hereto shall terminate  at,  and not survive, the Closing;
_provided_   that  this _Section  9.1_   shall  not limit any covenant or
agreement of the parties that by its terms requires  performance after the
Closing.

 

 

Section  9.2 _Fees  and Expenses_

 

 

(a) The  Company will pay (i) all costs and expenses incurred by the Company
and the  Stockholders in connection with the transactions contemplated by
this Agreement  (including, without limitation, attorneys\', accountants\',
brokers\', finders\'  and  investment banking fees and expenses), (ii) at
the Closing, all fees and  expenses of UBS Securities LLC and Banc of
America  Securities LLC, financial advisors to the Company, to the extent
such fees  and  expenses have not been previously paid or reimbursed and
(iii) any Employee  Merger Payments.

 

 

(b) Acquiror  shall bear all costs and expenses incurred by Acquiror and
MergerCo in  connection with the transactions contemplated by this Agreement,
including  (i)  the fees and expenses related to any filing made pursuant to
the HSR Act, (ii)  all fees, expenses or other costs incurred to obtain
contractual consents or  waivers and (iii) all amounts payable as a result of
any termination of  employment upon or following the Merger.

 

 

Section  9.3 _Amendment  and Modification_.  This  Agreement may be
amended only by a written agreement signed by Acquiror and  the  Company at
any time prior to the Closing Date with respect to any of the terms 
contained herein.

 

 

Section  9.4 _Waiver_.  No  failure or delay of any party in exercising any
right or remedy hereunder shall  operate as a waiver thereof, nor shall any
single or partial exercise of any  such right or power, or any abandonment or
discontinuance of steps to enforce  such right or power, or any course of
conduct, preclude any other or further  exercise thereof or the exercise of
any other right or power. The rights and  remedies of the parties hereunder
are cumulative and are not exclusive of any  rights or remedies that they
would otherwise have hereunder. Any agreement  on  the part of any party to
any such waiver shall be valid only if set forth in  a  written instrument
executed and delivered by a duly authorized officer on behalf  of such party.

 

 

Section  9.5 _Notices_.  All  notices and other communications hereunder
shall be in writing and shall be  deemed duly given (a) on the date of
delivery if delivered personally, or  if by facsimile, upon written
confirmation of receipt by facsimile, (b) on  the  first Business Day
following the date of dispatch if delivered utilizing a  next-day service by
a recognized next-day courier or (c) on the earlier of  confirmed receipt or
the fifth Business Day following the date of mailing if  delivered by
registered or certified mail, return receipt requested, postage  prepaid. All
notices hereunder shall be delivered to the addresses set forth  below, or
pursuant to such other instructions as may be designated in writing  by  the
party to receive such notice:

 

 

(a)   if  to the  Company, to:

 

 

 

 

 

 

 

46  

 

 

 

 

 

 

 

Harborside  Healthcare Corporation

 

One  Beacon Street

 

Boston,  Massachusetts 02108

 

Facsimile:  (617) 646-5646

 

Attention:  Bruce J. Beardsley

 

 

with  a  copy (which shall not constitute notice) to:

 

 

Investcorp  International Inc.

 

280  Park  Avenue

 

36th  Floor West

 

New  York,  New York 10017

 

Facsimile:  (212) 983-7073

 

Attention:  W. Christian McCollum

 

 

and

 

 

Gibson,  Dunn and Crutcher LLP

 

200  Park  Avenue

 

New  York,  New York 10166-0193

 

Facsimile:  (212) 351-4035

 

Attention:  E. Michael Greaney, Esq.

 

 

(b)   if  to  Acquiror, MergerCo or the Surviving Corporation, to:

 

 

Sun  Healthcare Group, Inc.

 

18831  Von  Karman

 

Suite  400

 

Irvine,  California 92612

 

Attention:  Michael Newman, Esq.

 

Facsimile:  (949) 255-7057

 

 

with  a  copy (which shall not constitute notice) to:

 

 

O\'Melveny  and Myers LLP

 

Times  Square Tower

 

7  Times  Square

 

New  York,  New York 10036

 

Attention:  Gregory Patti, Esq.

 

Facsimile:  (212) 326-2061

 

 

Section  9.6 _Interpretation_.  When a  reference is made in this Agreement
to a Section, Article or Exhibit such  reference shall be to a Section,
Article or Exhibit of this Agreement unless  otherwise indicated. The table
of contents and headings contained in this  Agreement or in any Exhibit are
for convenience of reference purposes only  and  shall not affect in any way
the meaning or interpretation of this Agreement.  All  words used in this
Agreement will be construed to be of such gender or number  as  the
circumstances require. Any capitalized terms used in any Exhibit but not 
otherwise defined therein shall have the meaning as defined in


 

 

 

 

 

 

 

47  

 

 

this Agreement. All Exhibits annexed  hereto or referred to herein are hereby
incorporated in and made a part of this  Agreement as if set forth herein.
The word "including" and words of similar  import when used in this Agreement
will mean "including, without limitation",  unless otherwise specified. 
 

 

Section  9.7 Entire  Agreement.  This  Agreement (including the Exhibits
and Schedules hereto) and the Confidentiality  Agreement constitute the
entire agreement, and supersede all prior written  agreements, arrangements,
communications and understandings and all prior and  contemporaneous oral
agreements, arrangements, communications and understandings  among the
parties with respect to the subject matter of this Agreement. This  Agreement
shall not be deemed to contain or imply any restriction, covenant, 
representation, warranty, agreement or undertaking of any party with respect 
to  the transactions contemplated hereby other than those expressly set forth
or  in  any document required to be delivered hereunder, and none shall be
deemed to  exist or be inferred with respect to the subject matter hereof.
Notwithstanding  any oral agreement of the parties or their Representatives
to the contrary,  no  party to this Agreement shall be under any legal
obligation to enter into or  complete the transactions contemplated hereby
unless and until this Agreement  shall have been executed and delivered by
each of the parties.

 

 

Section  9.8 _No  Third-Party Beneficiaries_.  Nothing  in this Agreement,
express or implied, is intended to or shall confer upon  any  Person other
than the parties and their respective successors and permitted  assigns any
legal or equitable right, benefit or remedy of any nature under  or  by
reason of this Agreement, except as provided in _Section  6.11_.

 

 

Section  9.9 _Governing  Law_.  This  Agreement and all disputes or
controversies arising out of or relating to this  Agreement or the
transactions contemplated hereby shall be governed by, and  construed in
accordance with, the internal laws of the State of New York,  without regard
to the laws of any other jurisdiction that might be applied  because of the
conflicts of laws principles of the State of New York (other  than  Section
5-1401 of the New York General Obligations Law).

 

 

Section  9.10 _Submission  to Jurisdiction_.  Each of  the parties
irrevocably agrees that any legal Action arising out of or relating  to this
Agreement or for recognition and enforcement of any judgment in respect 
hereof brought by any other party or its successors or assigns may be
brought  and determined in any New York State or federal court sitting in the
Borough  of  Manhattan in the City of New York (or, if such court lacks
subject matter  jurisdiction, in any appropriate New York State or federal
court), and each  of the parties hereby irrevocably submits to the
jurisdiction of the aforesaid  courts for itself and with respect to its
property, generally and  unconditionally, with regard to any such Action
arising out of or relating  to  this Agreement and the transactions
contemplated hereby (and agrees not to  commence any legal Action relating
thereto except in such courts). Each of  the  parties further agrees to
accept service of process in any manner permitted  by  such courts. Each of
the parties hereby irrevocably and unconditionally waives,  and agrees not to
assert, by way of motion or as a defense, counterclaim or  otherwise, in any
Action arising out of or relating to this Agreement or the  transactions
contemplated hereby, (a) any claim that it is not personally  subject to the
jurisdiction of the above-named courts for any reason other  than  the
failure lawfully to serve process, (b) that it or its property is exempt 
or  immune from jurisdiction of any such court or 

 

 

 

 

 

 

 

48  

 

 

 

 

 

 

from  any legal process commenced in such courts  (whether through service
of notice, attachment prior to judgment, attachment  in  aid of execution of
judgment, execution of judgment or otherwise) and (c) to  the  fullest
extent permitted by law, that (i) the Action in any such court is  brought in
an inconvenient forum, (ii) the venue of such Action is improper  or (iii)
this Agreement, or the subject matter hereof, may not be enforced  in or  by
such courts.

 

 

Section  9.11 Disclosure  Generally.  Notwithstanding anything to the
contrary contained in the _Disclosure  Schedules_   or in  this Agreement,
the information and disclosures contained in any _Disclosure  Schedule_  
shall be  deemed to be disclosed and incorporated by reference in any other
_Disclosure  Schedule_   as  though fully set forth in such _Disclosure 
Schedule_   for  which applicability of such information and disclosure is
reasonably apparent  on  its face. The fact that any item of information is
disclosed in any _Disclosure  Schedule_   shall  not be construed to mean
that such information is required to be disclosed  by  this Agreement. Such
information and the dollar thresholds set forth herein  shall not be used as
a basis for interpreting the terms "material" or "Material  Adverse Effect"
or other similar terms in this Agreement.

 

 

Section  9.12 _Personal  Liability_.  This  Agreement shall not create or
be deemed to create or permit any personal  liability or obligation on the
part of any direct or indirect stockholder of  the  Company or Acquiror or
any other Representative or investor of any party  hereto.

 

 

Section  9.13 _Assignment;  Successors_.  Neither  this Agreement nor any
of the rights, interests or obligations hereunder shall  be assigned by any
of the parties hereto without the prior written consent  of  the other
parties except that MergerCo may, without the obligation to obtain  the 
prior written consent of any other party, assign this Agreement or all or
any  part of its rights or obligations hereunder to 1 or more direct or
indirect  wholly-owned Subsidiaries of Acquiror (in all or any of which cases
Acquiror  shall remain responsible for the performance of all of its
obligations under  this Agreement). Subject to the foregoing, this Agreement
shall be binding  upon  and inure to the benefit of the parties hereto and
their respective successors  or permitted assigns, heirs, legatees,
distributees, executors, administrators  and guardians.

 

 

Section  9.14 _Enforcement_.  The  parties agree that irreparable damage
would occur in the event that any of  the  provisions of this Agreement were
not performed in accordance with their  specific terms or were otherwise
breached. Accordingly, each of the parties  shall be entitled to specific
performance of the terms hereof, including an  injunction or injunctions to
prevent breaches of this Agreement and to enforce  specifically the terms and
provisions of this Agreement in any New York State  or  federal court
sitting in the Borough of Manhattan in the City of New York (or,  if such
court lacks subject matter jurisdiction, in any appropriate New York  State
or federal court), this being in addition to any other remedy to which  they
are entitled at law or in equity. Each of the parties further hereby waives 
(a) any defense in any Action for specific performance that a remedy at law 
would be adequate and (b) any requirement under any law to post security as 
a prerequisite to obtaining equitable relief.

 

 

Section  9.15 _Severability_.  Whenever possible, each provision or portion
of any provision of this Agreement  shall be interpreted in such manner as to
be effective and valid under  applicable Law, but if any provision or portion
of any provision of this  Agreement is held to be invalid, illegal or
unenforceable in any respect under  any applicable Law or rule in any 
 

 

 

 

 

 

 

49  

 

 

 

 

 



 

jurisdiction,  such invalidity, illegality or  unenforceability shall not
affect any other provision or portion of any  provision in such jurisdiction,
and this Agreement shall be reformed, construed  and enforced in such
jurisdiction as if such invalid, illegal or unenforceable  provision or
portion of any provision had never been contained herein. 

 

 

Section  9.16 _Waiver  of Jury Trial_.  EACH OF  THE PARTIES TO THIS
AGREEMENT HEREBY IRREVOCABLY WAIVES ALL RIGHT TO A TRIAL  BY  JURY IN ANY
ACTION, PROCEEDING OR COUNTERCLAIM ARISING OUT OF OR RELATING TO  THIS
AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY.

 

 

Section  9.17 _Counterparts_.  This  Agreement may be executed in two or
more counterparts, all of which shall be  considered one and the same
instrument and shall become effective when one  or  more counterparts have
been signed by each of the parties and delivered to  the  other parties.

 

 

Section  9.18 _Facsimile  Signature_.  This  Agreement may be executed by
facsimile signature and a facsimile signature  shall  constitute an original
for all purposes.

 

 

Section  9.19 _Time  of Essence_.  Time is  of the essence with regard to
all dates and time periods set forth or referred  to in this Agreement.

 

 

Section  9.20 _No  Consequential Damages_.  The  parties hereto expressly
acknowledge and agree that no party hereto shall have  any liability under
any provision of this Agreement for any punitive,  incidental, consequential,
special or indirect damages, including business  interruption, loss of future
revenue, profits or income, or loss of business  reputation or opportunity
relating to the breach or alleged breach of this  Agreement.

 

 

Section  9.21 _Disclaimer  of Implied Warranties_.

 

 

(a) Notwithstanding  any other provision of this Agreement, Acquiror and
MergerCo acknowledge and  agree that neither the Company nor any other Person
has made any representation  or warranty, express or implied, as to the
accuracy or completeness of any  information regarding the Company or its
Subsidiaries, except as expressly  set  forth in this Agreement, and neither
Acquiror nor MergerCo is relying on any  information concerning the Company
except as so expressly set forth in this  Agreement.

 

 

(b) In  connection with Acquiror\'s investigation of the Company, Acquiror
has received  certain estimates, projections and other forecasts regarding
the Company and  its  Subsidiaries. Acquiror acknowledges that there are
uncertainties inherent in  attempting to make such estimates, projections and
other forecasts, that  Acquiror is familiar with such uncertainties and that
Acquiror is taking full  responsibility for making its own evaluation of the
adequacy and accuracy of  all  estimates, projections and other forecasts so
furnished to it (including the  reasonableness of the assumptions underlying
such estimates, projections and  forecasts). Accordingly, the Company makes
no representation or warranty with  respect to such estimates, projections
and other forecasts (including the  reasonableness of the assumptions
underlying such estimates, projections and  forecasts).

 

 

**[** The  remainder of this page is intentionally left blank. **]**

 

 

 

 

 

 

 

 

 

 

50  

 

 

 

 

 

 

 

 

 

IN  WITNESS WHEREOF, the parties have caused this Agreement to be executed as
of  the  date first written above by their respective officers thereunto
duly  authorized.

 

 

SUN  HEALTHCARE GROUP, INC.

 

 

 

By: _/s/  Richard K.  Matros  _ 
 Name: Richard K. Matros

 

  Title: Chief Executive Officer

 

 

 

 

 

HORIZON  MERGER INC.

 

 

 

By:   _/s/ William  Mathies _ 
 Name: William Mathies

 

  Title: President

 

 

 



 

 

 

 

 

 

 

   

 

 

 

 

 

 


HARBORSIDE  HEALTHCARE  CORPORATION

 

 

 

 

By:   _/s/ Damian  N.  Dell\'Anno   _ 
 Name: Damian N. Dell\'Anno

 

  Title: Chairman and Chief Executive Officer

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Signature  Page to Merger Agreement

 

 

 

 

 

 

 

   

 

 

 

 

 

 

 

SCHEDULES

 

 



 



 

        

1.1  (a)

    |  

Knowledge

    
---|--- 
     

4.1  (a)

    |  

Subsidiaries

    
     

4.3  (a)

    |  

Required  Filings and Consents

    
     

4.3  (b)

    |  

Required  Filings and Consents

    
     

4.4

    |  

CapitalizationCapitalization

    
     

4.5

    |  

Equity  Interests

    
     

4.6  (a)

    |  

Financial  Statements

    
     

4.7  (a)

    |  

Absence  of Certain Changes

    
     

4.8  (a)

    |  

Compliance  with Law

    
     

4.8  (b)

    |  

Health  Care Licenses

    
     

4.9

    |  

Litigation

    
     

4.10  (a)

    |  

Employee  Benefit Plans

    
     

4.10  (b) (ii)

    |  

Obligations  to be performed under Employee Plans

    
     

4.10  (b) (iii)

    |  

Actions  with Respect to Employees

    
     

4.10  (e)

    |  

Benefit  Plan Payments Due on Consummation

    
     

4.10  (g)

    |  

SERP

    
     

4.11  (a)

    |  

Collective  Bargaining Contracts; Labor Actions

    
     

4.12  (a)

    |  

Insurance

    
     

4.12  (b)

    |  

Insurance  Claims

    
     

4.13  (a)

    |  

Real  Property Owned

    
     

4.13  (b)

    |  

Real  Property Leased

    
     

4.13  (c)

    |  

Rights  of First Refusal

    
     

4.13  (d)

    |  

Condemnation  Proceedings

    
     

4.14 

    |  

Intellectual  Property

    
     

4.15

    |  

Taxes

    
     

4.16

    |  

Environmental  Matters

    
     

4.17  (a)

    |  

Material  Contracts

    
     

4.19

    |  

Indebtedness

    
     

4.20  (a)

    |  

Medicaid/Medicare  Compliance

    
     

4.20  (c)

    |  

Medicaid/Medicare  Contributions, Payments, etc.

    
     

5.3  (a) (ii)

    |  

Regulatory  Consents and Approvals

    
     

6.1

    |  

Conduct  of Business Prior to Closing

    
     

6.11  (b)

    |  

DandO  Insurance Premiums

    
     

7.1  (d)

    |  

Regulatory  Approvals

    
     

7.3  (d)

    |  

Consents  or Waivers for Certain Contracts

    
     

9.2  (a)

    |  

Employee  Merger Payments

    
    

 



 

(The  schedules listed above are not provided herein. However, Sun agrees to
furnish  such omitted schedules to the Commission upon request.)

 

 

 

 

 

 

 

 

   

 

 

 

 

 

 

       '

